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Abstract 
This paper examines the future of mortality in the 65 countries still experiencing high 
mortality in 2010, as defined by a cutoff of 40 deaths before age five per thousand live 
births. Mortality declines in several countries stagnated or reversed in the last two 
decades of the twentieth century due mainly to HIV/AIDS. The forces underlying past 
mortality trends and affecting the future course of mortality are examined by reviewing 
the existing literature and reporting the results of the global survey and invited meeting, 
both involving mortality experts. The experts assessed the likelihood and weight of 
forces hypothesized to influence mortality. A statistical model is combined with these 
expert assessments to produce a set of mortality assumptions that are incorporated into 
the projections reported in this paper. This paper also addresses the limited availability 
of reliable data on age-specific mortality rates. 
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The Future Mortality of High Mortality Countries: An Expert Based 
Model of Mortality 
Alessandra Garbero 
Elsie Pamuk 
1 Introduction 
The theory and empirical basis of the demographic transition includes the important role 
played by mortality declines in generating a societal shift from high mortality and high 
fertility to low mortality and low fertility. In particular, it is the improved survival of 
children into adulthood that initially produces increasingly large populations with a very 
young age structure. Because the level of childhood mortality is strongly linked to 
fertility levels (Angeles 2010; Becker & Barro 1988) and adult mortality rates, the 
definition of a high mortality country used in the Wittgenstein Centre for Demography 
and Global Human Capital (WIC) expert opinion survey reported in this paper is in 
terms of the level of childhood mortality, that is, the probability of death before age five 
(5q0 in the life table designation). 
In accordance with recent practice at WHO and UNICEF in monitoring progress 
toward the Millennium Development Goals (MDG), we use a cutoff point of 40 deaths 
per thousand live births before the age of five years to designate a country as having 
high mortality (Hill et al. 2012). In 2010, the under-five mortality rate exceeded 40 in 
one-third of the 193 member countries of United Nations, and in only one of these 
countries did life expectancy at birth exceed 70 years (Azerbaijan, e0 = 70.1) (United 
Nations 2011b). Despite its relatively low under-five mortality rate (estimated at 0.025 
in 2011), Botswana is also considered here as a country with high mortality because its 
life expectancy is estimated at 53 years (United Nations, 2011). The geographic 
distribution of these countries is shown in Figure 1, while Table 1 lists all 65 high 
mortality countries, along with current estimates of life expectancy, child and adult 
mortality and the change in life expectancy between the periods 1995-2000 and 2000-
2011. 
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Figure 1. Geographic distribution of high mortality countries discussed in this paper 
 
Table 1. Countries with high mortality 
Selection criterion = 5q0>40/1000   Life Expectancy (e0) 
in years 
(both sexes) 
 
Under- Five 
mortality 
(5q0)  per 
1000 live 
births 
(both sexes) 
      UN – WPP 2010 IGME 
e0 
rank 
Country Population 
(thousands) 
2010 
HIV affected Decadal 
gain in e0 
(2005-10 - 
1995-
2005) 
2005-2010 2011 
Africa – Eastern      
4 Zimbabwe 12 571 hiv -1.6 46.6 67.1 
6 Zambia 13 089 hiv 4.3 46.9 82.9 
11 Mozambique 23 391 hiv 2.0 48.8 103.1 
12 Burundi 8 383 hiv 3.4 48.8 139.1 
17 Somalia 9 331  3.4 50.2 180.0 
20 Malawi 14 901 hiv 5.4 51.6 82.6 
21 Uganda 33 425 hiv 7.2 52.2 89.9 
27 Rwanda 10 624 hiv 12.3 53.9 54.1 
30 Kenya 40 513 hiv 1.1 55.0 72.8 
31 United Republic of Tanzania 44 841 hiv 5.7 55.4 67.6 
34 Djibouti 889 hiv 3.4 56.6 89.5 
35 Ethiopia 82 950 hiv 6.7 57.2 77.0 
39 Comoros 735  2.3 59.7 79.3 
40 Eritrea 5 254 hiv 5.5 60.0 67.8 
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Selection criterion = 5q0>40/1000   Life Expectancy (e0) 
in years 
(both sexes) 
 
Under- Five 
mortality 
(5q0)  per 
1000 live 
births 
(both sexes) 
57 Madagascar 20 714  8.5 65.8 61.6 
Africa - Middle & Northern       
1 Central African Republic 4 401 hiv 1.3 45.9 163.5 
9 Democratic Republic of the Congo 65 966 hiv 2.3 47.4 167.7 
10 Chad 11 227 hiv -0.7 48.5 169.0 
13 Angola 19 082 hiv 6.3 49.6 157.6 
14 Cameroon 19 599 hiv -1.0 50.0 127.2 
16 Equatorial Guinea 700 hiv 1.5 50.1 118.1 
33 Congo 4 043 hiv 1.7 56.0 98.8 
45 Gabon 1 505 hiv 0.7 61.3 65.6 
50 Sao Tome and Principe 165  1.8 63.8 88.8 
41 Sudan 43 552  4.9 60.3 86.0 
Africa – Southern      
2 Lesotho 2 171 hiv -6.5 46.0 86.0 
8 Swaziland 1 186 hiv -5.4 47.4 103.6 
19 South Africa 50 133 hiv -6.5 51.2 46.7 
25 Botswana 2 007 hiv -1.6 53.3 25.9 
44 Namibia 2 283 hiv 1.6 61.1 41.5 
Africa – Western      
3 Sierra Leone 5 868 hiv 8.2 46.3 185.3 
5 Guinea-Bissau 1 515 hiv 2.5 46.8 160.6 
15 Mali 15 370 hiv 3.4 50.0 175.6 
18 Nigeria 158 423 hiv 5.0 50.3 124.1 
22 Guinea 9 982 hiv 5.8 52.4 125.8 
23 Côte d'Ivoire 19 738 hiv 2.7 53.0 114.9 
24 Niger 15 512  6.7 53.1 124.5 
26 Burkina Faso 16 469 hiv 4.3 53.9 146.4 
28 Liberia 3 994 hiv 11.0 54.4 78.3 
29 Benin 8 850 hiv 2.7 54.6 106 
32 Togo 6 028 hiv 1.2 55.7 110.1 
36 Gambia 1 728 hiv 3.0 57.3 106 
37 Mauritania 3 460  0.7 57.5 112.1 
38 Senegal 12 434  3.2 58.2 64.8 
48 Ghana 24 392 hiv 4.9 62.7 77.6 
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Selection criterion = 5q0>40/1000   Life Expectancy (e0) 
in years 
(both sexes) 
 
Under- Five 
mortality 
(5q0)  per 
1000 live 
births 
(both sexes) 
Asia – Southern      
7 Afghanistan 31 412  2.8 47.3 101.1 
52 India 1 224 614 hiv 3.5 64.2 61.3 
54 Pakistan 173 593  2.0 64.6 72.0 
58 Bhutan 726  6.9 65.8 53.7 
61 Nepal 29 959  7.8 67.4 48.0 
63 Bangladesh 148 692  4.4 67.8 46.0 
Asia - South-East      
42 Timor-Leste 1 124  7.0 60.8 54.1 
47 Cambodia 14 138  4.8 61.5 42.5 
49 Myanmar 47 963  2.4 63.5 62.4 
59 Lao People's Democratic Republic 6 201  6.1 66.1 41.9 
Asia -Central & Western      
55 Turkmenistan 5 042  1.1 64.6 52.5 
60 Tajikistan 6 879  3.6 66.4 63.3 
62 Uzbekistan 27 445  0.7 67.4 48.6 
51 Yemen 24 053  5.7 63.9 76.5 
65 Azerbaijan 9 188  4.1 70.1 44.7 
Latin America      
43 Haiti 9 993 hiv 3.0 61.0 70.0 
56 Bolivia (Plurinational State of) 9 930  3.5 65.6 50.6 
Oceania      
46 Papua New Guinea 6 858  3.5 61.5 57.8 
64 Micronesia (Fed. States of) 111  1.3 68.3 41.5 
53 Kiribati 100  4.6 64.4 47.4 
    
range = -6.5 - 12.3 45.9 – 70.1 25.6-185.3 
 
As shown, high mortality countries include all of sub-Saharan Africa except the 
island nations of Cape Verde, Mauritius, Mayotte and Reunion. Most of South Asia 
meets the criterion of high mortality, including the populous countries of India, Pakistan 
and Bangladesh.  
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1.1 Past Trends and Current Levels 
Many demographers have, over the last 50 years, predicted a general convergence 
worldwide toward low mortality and fertility resulting in higher levels of life 
expectancy. The presumption of global convergence in mortality was based on analyses 
of mortality data, primarily from developed countries, starting from the 1960s 
(McMichael et al. 2004). These data revealed the occurrence of a common pattern, 
named the “epidemiological transition” (Omran 1971), broadly indicating not only that 
declines in death rates from infectious diseases (affecting mainly children and younger 
adults ) cause increases in life expectancy, but also leave the remaining mortality as  
primarily due to non-communicable diseases, largely occurring in old-age. The apparent 
pervasiveness of this pattern gave some expectation of a rapid decline of mortality in 
high mortality countries, while countries that had already achieved a relatively low level 
of mortality would find future increases in life expectancy harder to achieve. 
However, the idea of a global convergence in mortality has been challenged by 
the occurrence of mortality reversals during the last two decades. These reversals took 
place in countries that experienced conflict (i.e. Rwanda, Angola, Sierra Leone, Liberia, 
and Somalia), failure of health systems (i.e. Kazakhstan and Zimbabwe), or HIV and 
AIDS epidemics (Reniers et al. 2011). In 2004, HIV and AIDS was the fourth leading 
cause of death in low income countries, followed by deaths from lower respiratory 
infections, ischemic heart disease, and diarrheal diseases (Mathers et al. 2008). 
Increases in malaria and tuberculosis have also been partly responsible for mortality 
trend reversals in the last two decades, in sub-Saharan Africa and in other regions.  
In addition, progress toward reducing infant and child mortality has stagnated or 
slowed in many countries, due not only to HIV/AIDS and conflicts, but also because of 
increases in malaria-related mortality and stalls in immunization rates in the 1990s. 
Other factors contributing to this divergent trend are the growing burden of injuries and 
non-communicable diseases, as well as health risks due to environmental changes, 
induced or not by human pressures. Often, several factors combine to adversely affect 
mortality trends. For example, life expectancy has been severely affected in Haiti 
(Farmer et al. 2003) as a consequence of aid restrictions in a context of widespread  
poverty and a failed health system.  
A serious problem in estimating past trends and projecting the future course of 
life expectancy in high mortality countries is the lack of reliable data on age-specific 
mortality rates, particularly for adults. Among the 65 countries considered here, only 
Azerbaijan, Turkmenistan, Uzbekistan and São Tomé and Príncipe have vital 
registration systems covering at least 90 percent of deaths1. The coverage of death 
registration in South Africa hovers around 85 percent, and until recently, vital 
registration data could be used in Zimbabwe as well (Feeney 2001). In other countries, 
either the coverage is far too low for estimating mortality or vital statistics are not 
compiled and transferred to national statistical offices (Mathers et al. 2005). Because of 
this lack of registration-type data, trends in child mortality are generally obtained from 
direct or indirect methods making use of mothers’ reports on the survival of their 
children, as collected in censuses and large-scale surveys (DHS, MICS, etc.). For adult 
                                                 
1
 Source: United Nations Statistics Division (n.d), Coverage of Birth and Death Registration, retrieved 
November 7, 2012 from http://unstats.un.org/unsd/demographic/CRVS/CR_coverage.htm 
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mortality, no equivalent approach has proved entirely satisfactory (Hill et al. 2005). 
Converting the cohort attrition between two census age distributions into measures of 
adult mortality poses several difficulties, mainly due to age misreporting, differences in 
the completeness of the censuses, and migrations (Preston 1983). Several death 
distribution methods have been designed to evaluate and to potentially adjust [upwards] 
mortality rates computed from recent household deaths or incomplete vital registration 
(Hill 1987), but these methods are hard to apply when net migration is substantial and 
they are based on rather stringent assumptions (such as a constant underreporting of 
deaths over a certain age limit). A third series of methods makes use of survey and 
census reports on the survival status of close relatives, that is, first spouses, siblings or 
parents (Hill & Trussell 1977; Hill 1987). The rare studies that exploited data on the 
survival of first spouses were not very encouraging (Makinson 1993; Timaeus 1987), 
and the method has since fallen into disuse. Probabilities of dying inferred from data on 
orphanhood also tend to underestimate adult mortality and they can be heavily distorted 
by HIV-related biases. By contrast, the data on the survival of siblings that have been 
collected in more than a hundred Demographic and Health Surveys (DHS) are emerging 
as a major source of estimates of adult mortality in developing countries. The main 
advantage of sibling survival data is that they provide occurrence/exposure-type 
mortality rates when full sibling histories are collected from adult household members. 
Limited modeling is required to derive age- and period-specific mortality rates 
(Timaeus & Jasseh 2004), yet substantial biases can affect these retrospective data as 
well (Helleringer et al. 2013; Masquelier 2013).  
Against this backdrop of paucity and poor quality of data on mortality, the next 
section describes what is known about trends in child and adult mortality in high 
mortality countries, using the best data available, for the 65 countries classified as 
having high mortality in 2010. 
2 Child Mortality: Current Levels and Past Trends  
An advantage of using early childhood mortality as the defining criterion for 
designating a country as having high mortality is that considerable effort is being made 
by the United Nations Inter-agency Group for Child Mortality Estimation (IGME) to 
form the most reliable estimates for every country in the world. The IGME collects and 
assesses the quality of all available data, then uses acceptable data and recognized 
statistical methods to form time series estimates of mortality before the age of five. New 
estimates for countries and world regions through 2011 have recently been made 
available (Hill et al. 2012), and provide the basis for the description of current levels 
and past trends contained in the following section. 
Since 1990, the global under-five mortality rate has dropped by 41 percent—
from 87 deaths per 1,000 live births in 1990 to 51 in 2011 (UNICEF 2012). In the 
majority of countries including many developing countries, the under-five mortality rate 
has been cut in half in the past two decades. At the same time, however, the disparity 
between areas where child mortality remains high and the rest of the world has 
increased. As shown in Figure 2, child mortality is increasingly concentrated in sub-
Saharan Africa and South Asia; over 80 percent of child deaths in 2011 occurred in 
these two regions. Yet even within this group of high mortality countries, the level of 
child mortality varies considerably. The under-five mortality rate in Sierra Leone, the 
country with the highest rate in 2011, was four and a half times greater than the rates for 
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Micronesia, Lao PDR and Namibia, and 7 times greater than that for Botswana (Table 
1). 
The difficulty involved in making accurate projections of future trends in life 
expectancy for countries with high levels of mortality is illustrated by examining the 
trends in child mortality within these countries over the past three decades, time periods 
for which reasonably reliable estimates of child mortality levels have been made (You 
et al. 2011). 
Figure 2 to Figure 7 show the trends in the under-five mortality rate for countries 
separated by region. For regions with many high mortality countries, the overall trend 
and distribution is indicated by a series of boxplots accompanied by examples of 
different country-specific trends to indicate the range of variation in the patterns. The 
countries shown in the right-hand panel are those with the greatest and slowest rate of 
change between 1980 and 2011, those with the highest and lowest mortality rates in 
2011, and examples of atypical trends. 
In 1980 the fifteen countries of Western Africa experienced very high child 
mortality, averaging 226 (deaths to children less than 5 years of age for every 1000 live 
births) and ranging from a high of 317 in Niger to a low of 155 in Ghana (Figure 2). 
Over the next 3 decades, the rate of child mortality declined in every country, but the 
amount of decline varied from 67-68 percent in Liberia and Senegal to just 29-30 
percent in Mauritania and Sierra Leone. For many Western African countries, the 
declines in child mortality have been steady, albeit at different rates, as typified by 
Ghana and Guinea-Bissau (Figure 2 – right panel). However, for Sierra Leone, Niger, 
Liberia and Nigeria, little or no progress was made between 1980 and the mid- to late- 
1990s, followed by much more rapid declines in the last decade. By 2011, the average 
child mortality rate for these countries was 120 and ranged from 185 in Sierra Leone to 
65 in Senegal, but the variation in the pattern and pace of decline produced a quite 
different ranking of countries by level of child mortality in 2011 compared with 1980. 
Figure 2. Trends in the under-five mortality rate, Western Africa. 
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Figure 3 shows a generally similar overall pattern for the 15 countries of Eastern 
Africa. In 1980 child mortality in these countries averaged 182 and ranged from 256 in 
Malawi to a low of 104 in Zimbabwe. By 2011 child mortality had declined by an 
average of 52 percent to 88. However, the variation in the pace of decline across these 
15 countries was even more striking than in Western Africa. Estimates of declines 
ranged from 75 percent in Rwanda to only 30 percent in Burundi and to no change in 
Somalia. In most countries of Eastern Africa, the pace of decline in child mortality was 
slow or non-existent until the mid- to late-1990s (Figure 3). The recent declines have 
tended to be more rapid in countries where child mortality was higher initially, resulting 
in less variation across the region in 2011 than in 1980-2000. By 2011 all but 3 of the 
Eastern African countries had estimated child mortality rates between 54 and 90. 
Figure 3. Trends in the under-five mortality rate, Eastern Africa. 
Overall, the 11 countries of Middle and Northern Africa have seen less progress 
in reducing child mortality (Figure 4). In 1980 the average child mortality rate was 186, 
ranging from 286 in Angola to 96 in São Tomé and Príncipe. By 2011 the average had 
fallen to 124, a decline of just 33 percent. The greatest decline was estimated to have 
occurred in South Sudan (56 percent), while only minimal declines were seen for the 
Central African Republic (7 percent) and São Tomé and Príncipe (8 percent). Although 
declines tended to be more substantial for countries with higher child mortality in 1980, 
such as Angola and South Sudan, the reduction in variation was not as great as that seen 
in Eastern Africa. In 2011, under-5 mortality rates ranged from 66 in Gabon to 166 in 
the Democratic Republic of Congo. 
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Figure 4. Trends in the under-five mortality rate, Middle and Northern Africa. 
It is in Southern Africa that the impact of the AIDS epidemic on child mortality 
trends is the most obvious (Figure 5). In 1980, child mortality was already lower in this 
region compared to the rest of sub-Saharan Africa, averaging 100 deaths per 1000 live 
births and ranging only between 121 in Lesotho to 78 in Botswana. In addition, child 
mortality continued to decline between 1980 and 1990 in all 5 countries, but by 2000 
these gains had been completely reversed in Botswana, Lesotho and Swaziland and 
nearly reversed in South Africa and Namibia. Child mortality has started to fall again in 
the last decade, and at a more rapid rate in the countries that already had lower child 
mortality (Botswana, Namibia and South Africa). As a result, variation in child 
mortality across these 5 countries was substantially greater in 2011 than at any previous 
time; ranging from 26 in Botswana to 104 in Swaziland. 
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Figure 5. Trends in the under-five mortality rate, Southern Africa. 
In general, declines in child mortality were much larger and more consistent in 
the high mortality countries in Asia. The 5 high mortality countries of Central and 
Western Asia have each seen their child mortality rates decline by between 49 and 61 
percent since 1980 (Figure 6). The declines in child mortality in Southern Asia have 
been even greater, averaging 67% since 1980. However, it is notable that child mortality 
declined less in India and Pakistan, the countries with the lowest levels in 1980, than in 
all other countries in the region. By 2011, Afghanistan was the only country in South 
Asia with higher child mortality than in India and Pakistan. Progress has been even 
more striking in the remaining high mortality countries of Southeastern Asia (Figure 7). 
Since 1982, the child mortality rate has been reduced by 77 percent in Lao PDR and 
Timor-Leste and by 72 percent in Cambodia, despite the period of stagnation between 
1985 and 1998. Even in Myanmar, the child mortality rate is estimated to have fallen by 
over 50 percent since 1982. 
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Figure 6. Trends in the under-five mortality rate, Central, Western and Southern Asia. 
Figure 7. Trends in the under-five mortality rate, South-East Asia, Latin America and 
Oceania. 
The remaining ‘high’ mortality countries are divided between Latin American 
and Oceania (Figure 7). The two Latin American countries, Bolivia and Haiti, have seen 
child mortality decline by more than 60 percent since 1980, despite the 2010 earthquake 
in Haiti. Declines in childhood mortality have been less steep in the three island nations 
of Oceania. The disparity across the ‘high’ mortality countries in these 30 year trends in 
child mortality reinforces the difficulty of making predictions about the future course of 
life expectancy without linking these predictions to the forces determining the progress 
– or lack thereof – in combatting the underlying determinants of both child and adult 
mortality peculiar to each of these countries. The direct causes of childhood death in 
high mortality countries are predominately pneumonia, diarrhea, malaria, pre-term birth 
and complications during birth. But since these direct causes are amenable to both 
treatment and prevention, we need to look further to assess the prospects for future 
trends. The UN has estimated that over one-third of deaths to children under the age of 
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five can be attributed to undernutrition (UNICEF 2012). Many underlying forces in turn 
affect the extent to which a country can provide adequate nutrition and basic health 
services for its children.  
What is clear from an examination of the most recent decadal changes in child 
mortality in all high mortality countries is that rapid improvement can be achieved, even 
under less than ideal circumstances. Between 2000 and 2011, the IGME estimates that 
the child mortality rate declined by 30 percent or more in 29 of the 66 high mortality 
countries and by 50 percent or more in 6 (Rwanda, Botswana, Cambodia, Liberia, 
Timor-Leste and Senegal). Over the same period however, child mortality declined by 
less than 10 percent in many countries with some of the highest child mortality levels: 
Somalia, São Tomé and Príncipe, Central African Republic, Mauritania, Congo DR, 
Congo, Cameroon and Swaziland. 
Adding to the challenges of predicting future trends in child mortality is the 
uncertainty regarding past trends and current levels. Although the methods employed by 
the IGME have generated far better estimates than previously available, continual 
improvement in both data and methods is anticipated. Each improvement results in 
changes to the existing ‘best available’ estimates, as shown by a comparison of 2010 
and 2011 IGME estimates for high mortality countries. Still, our knowledge of levels 
and trends in child mortality for high mortality countries with inadequate death 
registration greatly exceeds that for adult mortality in these same countries, as shown in 
the following section. 
 
3 Adult Mortality 
3.1 Adult Mortality in sub-Saharan Africa  
African nations are experiencing the heaviest burden of adult mortality worldwide. In 
the period 2005-2010, all countries in which the life expectancy at age 15 was lower 
than 50 years were located in sub-Saharan Africa, with the notable exception of 
Afghanistan (United Nations 2011b). This summary measure of adult mortality varied 
from 38 years in Zimbabwe to 56 years in Madagascar. Its average value, estimated at 
48 years, remained almost 10 years below the corresponding value for South-Eastern 
Asia (57). In addition, whereas the life expectancy at age 15 increased by about five 
years in the last 25 years in South-Eastern Asia, it has remained virtually unchanged in 
sub-Saharan Africa. Only a handful of countries have benefited from substantial 
improvements in adult survival (Eritrea, Ethiopia, and Madagascar), whereas life 
expectancy in adults aged 15 years and over has declined since the 1980s in about 20 
countries.  
A detailed account of trends in adult mortality in the region remains elusive 
because of the lack of reliable and comprehensive data sources. As mentioned earlier, 
the partial absence of comprehensive registration systems forces demographers to resort 
to indirect and unconventional techniques: intercensal survival methods, death 
distribution methods, and approaches based on orphanhood or sibling data. However, 
the resulting estimates are often discrepant and refer only to a few points in time. In 
 13 
addition, the development of these techniques often predates the emergence of AIDS as 
a major cause of death. The epidemic has since introduced serious breaches in many of 
assumptions underpinning these techniques. For most African countries, the Population 
Division of the United Nations (UNPD) thus resorts to the long-standing tradition of 
combining child mortality rates with model mortality schedules, and making ad-hoc 
adjustments for HIV/AIDS (Masquelier et al. 2013). First, a complete life table that 
pertains to the population not infected by HIV (also referred to as the background 
mortality) is estimated. Then, for countries where HIV prevalence ever exceeded two 
percent, estimates of background mortality are supplemented by AIDS deaths calculated 
via an epidemiological multi-state model. This model is analogous to the Spectrum 
model used by UNAIDS (Stover et al. 2010; Stover et al. 2008). The resulting estimates 
of overall mortality are then compared to existing empirical data. When important 
discrepancies with model outputs are apparent, the background mortality is revised and 
the procedure is repeated until a reasonable agreement is achieved (United Nations 
2005). Likewise, the WHO employs estimates of AIDS deaths from UNAIDS and adds 
them to the background mortality rates derived from child mortality estimates and a 
modified Brass logit model (Murray et al. 2003). Recently, the Institute for Health 
Metrics and Evaluation (IHME) has also produced its own set of mortality estimates for 
the Global Burden of Disease 2010 Study (Rajaratnam et al. 2010). The calculation of 
age and sex-specific mortality rates was performed in three steps (Wang et al. 2012). 
First, empirical measurements of the probabilities of dying in childhood (5q0) and 
between ages 15 and 60 (45q15) were extracted from survey, census and vital 
registration data, and adjusted for various biases. Second, trends in these two summary 
indices were fitted through a method known as Gaussian process regression (GPR), with 
a series of covariates including education and lagged distributed income. Third, a 
complete life table was derived from fitted trends in 5q0 and 45q15 by using yet another 
relational life table system. Some important differences with the methods used by the 
UNPD or the WHO are the use of covariates and the reliance on survey data on the 
survival of siblings, which often provide lower levels of adult mortality, as will be 
shown below. 
The UNPD mortality rates are probably the most reliable estimates to date, 
mainly because they are subject to a careful comparison with other existing data and 
they are obtained by ensuring consistency with other components of the demographic 
dynamic (fertility and migration). That said, they are underpinned by a complex 
modeling of the HIV epidemic that involves several parameters known to have large 
uncertainties, such as the HIV incidence by age and sex, or, more recently, the coverage 
of antiretroviral therapies. In addition, in a majority of high mortality countries, trends 
in the non-aids mortality are inferred from child mortality, which can be misleading if 
adult and child mortality have not evolved in concert. 
Data on sibling survival collected in DHS provide useful counterpoints to these 
estimates. Masquelier et al. (2013) compared the probability of dying between the ages 
15 and 60 (45q15) from the 2010 Revision of the World Population prospects (WPP) and 
sibling survival data for sub-Saharan Africa. We summarize here their main 
observations and present a brief overview of mortality trends in the following plots, 
applying their estimation method also to DHS conducted outside of sub-Saharan Africa.  
The boxplot in Figure 8 displays the probability of a male dying between ages 
15 and 60 (45q15)  in 18 countries located in Western and Middle Africa (plus North 
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Sudan)2, in which at least one set of sibling survival data was collected in the DHS. 
Trends from the 2010 Revision of the WPP (United Nations 2011b) are presented 
alongside estimates derived from DHS. Sibling estimates largely fare as lower bound 
estimates. The right-hand side of Figure 8 singles out some countries and compares 
WPP estimates (solid lines) with DHS estimates (dashed lines). In Senegal, for example, 
the male probability 45q15   for 2004 is about 35 percent higher in the WPP than in the 
DHS. Large discrepancies are also found in Cameroon prior to 2000, while there is a 
better agreement in Ghana. 
Figure 8. Trends in the probability of male dying between ages 15 and 60 in 18 
countries in Middle, Western Africa and North Sudan, from the 2010 Revision of the 
World Population Prospects and DHS sibling histories. 
 
Estimates in Eastern and Southern Africa can be quite discrepant as well, as 
illustrated with Malawi, (Figure 9), for which sibling-based estimates are lower in the 
pre-AIDS period, but higher in recent years. Reniers et al. (2011) already noted that 
discrepancies between WPP and DHS estimates are larger in settings with small HIV 
prevalence, especially in the Sahelian countries. They speculated about the reasons for 
this and suggested that recall errors could be more pervasive in surveys conducted in 
Western Africa because of greater complexity of family structures (due to higher 
fertility rates and polygyny). Another explanation is that sibling histories underestimate 
mortality irrespective of the region, but this is obfuscated in countries affected by 
HIV/AIDS. This could be the case if WPP estimates were themselves too low in these 
countries, potentially because of recent downward revisions of HIV prevalence (Reniers 
& Eaton 2009). However, this explanation needs to be supported by further 
investigations. 
                                                 
2
 North Sudan is the only country from Northern Africa covered by sibling data (apart from Morocco, not 
included here), because South Sudan was not covered in the 1989-90 DHS. The 2010 WPP estimates 
refer to the former Sudan. Estimates for Rwanda in 1993 or 1998 are not included in the graphs due to the 
extremely high mortality levels related to the genocide. DHS estimates for Middle and Western Africa are 
only presented up to 2003 because few countries have conducted a DHS with sibling histories after 2008.  
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Figure 9. Trends in the probability of male dying between ages 15 and 60 in 15 
countries in Eastern and Southern Africa, from the 2010 Revision of the World 
Population Prospects and DHS sibling histories. 
 
Despite these methodological issues, some common trends can be isolated from 
both sources (Figure 8 and Figure 9, Table 2). In Middle and Western Africa, adult 
mortality mostly stagnated at relatively high levels. Increases in mortality have also 
occurred since 1985 in a few countries, either because of high HIV prevalence (in the 
case of Cameroon and Côte d’Ivoire) or civil unrest (Democratic Republic of the 
Congo). According to the DHS, the post-civil war period in Congo-Brazzaville is the 
only case in this region where adult mortality declined sharply during the 1990s.  
In Eastern and Southern Africa, with the exceptions of Ethiopia, Madagascar 
and Burundi (in the period post-2000), all countries covered by DHS sibling histories 
have experienced mortality increases. These have been the largest in Lesotho, Malawi, 
Namibia, Rwanda (during the genocide), Swaziland, Uganda, Zambia and Zimbabwe. 
In several cases, however, mortality rates have peaked and seem to be declining. Some 
of these peaks occurred before the rapid scale-up of ART programs (Zimbabwe, 
Zambia, Tanzania, Uganda). In Southern Africa, adult mortality levels are still on the 
rise in Lesotho, Namibia and Swaziland.  
Standard DHS do not collect information on causes of deaths, apart from 
questions aimed at identifying pregnancy-related causes. Information on the underlying 
structure of causes of death thus come either from (1) hospital records, (2) death 
registration for specific areas, such as in South Africa and some urban centers 
(Waltisperger & Meslé 2005), or (3) Health and Demographic Surveillance sites 
(HDSS). The latter refer to geographically localized populations in which a recurrent 
collection of demographic events (eg. every four months) is organized. More than 20 
sites exist in Africa (many are part of the INDEPTH Network) and cover populations 
ranging from 50,000 to 200,000 (Network 2005). Information on causes of death come 
from “verbal autopsies” conducted with caregivers and relatives of the deceased. Adjuik 
et al. (2006) reviewed these data and concluded that infectious diseases remain the 
leading causes of death among adults aged 15 and older in African HDSS. This is 
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predominantly due to AIDS (causing as much as 53 percent of adult deaths in ACDIS, 
KwaZulu-Natal), tuberculosis (ranging from two percent of deaths in Nouna, Burkina 
Faso, to 19 percent in Butajira, Ethiopia), and malaria (causing about a quarter of adult 
deaths in Niakhar, Senegal). Evidence is also accumulating that sub-Saharan Africa is 
facing an epidemic of non-communicable diseases (Dalal et al. 2011), including 
cardiovascular disease, cancer and metabolic diseases. Rather than the expected 
transition from communicable diseases to non-communicable diseases, the sub-
continent thus faces a double burden.  
3.2 Adult Mortality in Asia 
The measurement of adult mortality has also proven to be difficult in Asia. Mortality 
data simply did not exist in most Asian countries until the mid to late 20th century (Zhao 
2011). Data from only 11 Asian populations contributed to the development of the 
United Nations Model Life Tables for Developing Countries in the early 1980s (United 
Nations 1982). Since then, the frequency of censuses increased but Asia is still lagging 
behind in terms of data quality. Demographic and health surveys have also played an 
important role and managed to fill some of the data gaps. In addition, as in the African 
region, the UNPD and the WHO have made considerable efforts to evaluate and adjust 
available data and correct for underreporting and enumeration errors.  
The first three plots in Figure 10a, b present adult mortality estimates for males 
in Asian countries that fall within our classification criterion. These are based on 
estimates from the World Population Prospects (solid lines). The corresponding regions 
are Southern Asia, South East Asia, and a few countries in Central and Western Asia. 
For countries in these regions, the estimates of the probability 45q15 in the WPP are only 
available for the period 1995-20103. Data on sibling survival have only been collected 
in Afghanistan, Nepal, Bangladesh, Cambodia and Timor-Leste. The corresponding 
estimates appear with dashed lines.  
                                                 
3
 Estimates are available from 1980 onwards for countries for which an explicit modeling of HIV/AIDS is 
made by the UNPD, as is the case in most African countries.  
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Figure 10a, b. Trends in the probability of male dying between ages 15 and 60, by 
region, from the 2010 Revision of the World Population Prospects and DHS sibling 
histories.  
A number of countries, mostly in the Southern and Central region, have 
experienced either a slow decline or no remarkable change in the level of adult mortality 
in the period 1990-2005, as portrayed by these most recent estimates by the UN. Such 
countries are Afghanistan, Pakistan, India, Turkmenistan, and Uzbekistan. Afghanistan 
is the country where life expectancy was estimated at 47 years in 2005-2010 according 
to the 2010 Revision of the World Population Prospects, faring as the lowest life 
expectancy at birth in Asia (United Nations 2011b). But there are large uncertainties 
around these mortality estimates. In the recently released 2012 Revision of the WPP, 
mortality rates for Afghanistan have been revised downwards, with life expectancy 
reaching 58 years in 2005-2010. This revision was based on the 2010 Afghanistan 
Mortality Survey (AMS), in which low levels of child and adult mortality were 
reported. For example, the trend in adult mortality inferred from sibling data collected 
in this survey are presented in Figure 10a, b. These estimates should not be taken at face 
value, however, as several indicators point to poor data quality, such as very high sex 
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ratios of reported siblings and a large fraction of deaths reported as having occurred 
exactly 10 years prior to the survey. In addition, approximately 13 percent of the 
population was not surveyed because of security or other issues.  
In order to shed light on the heterogeneous cause-of-death structure that is 
characteristic of Asia, the percent distribution of adult deaths by cause is displayed in 
Figure 11 to Figure 12 for both sexes, based on the 2008 WHO estimates of deaths due 
to diseases and injury (World Health Organization 2011). Adult deaths (15-59) were 
disaggregated by cause according to the major ICD-10 groupings (World Health 
Organization 1992) i.e. communicable, non-communicable, and injury deaths. Deaths 
from “infectious and parasitic diseases” were extracted from communicable diseases to 
understand their role in the countries under study. HIV and AIDS, and tuberculosis-
related deaths were also isolated from the subgroup “infectious and parasitic diseases” 
to show their weight in the countries under study.  
In general in high mortality Asian countries, factors that have contributed to 
these high adult mortality trends are wars, social unrest, the collapse of the USSR, the 
spread of HIV and AIDS and, to a certain extent, a low level of socio-economic 
development.  
In Southern Asia (Figure 11), although these countries are still in the later stage 
of the epidemiological transition, the high levels of adult mortality can be attributed to 
non-communicable diseases, although communicable diseases as a whole (including 
infectious and parasitic diseases) still account for a large share.  
 
Figure 11. Distribution of adult deaths by major cause (%), Southern Asia  
Authors’own calculations based on WHO 2011 data.  
In South-East Asia (Figure 12), communicable diseases -- particularly infectious and 
parasitic diseases – prevail, with Timor-Leste and Cambodia showing a large burden 
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due to HIV and TB-related adult deaths. Cambodia and Lao People’s Democratic 
Republic also exhibit a large share of adult deaths due to non-communicable diseases. A 
significant burden from injury deaths is present in Myanmar.  
Figure 12. Distribution of adult deaths by major cause (%), South-East Asia 
Authors’ own calculations based on WHO 2011 data.  
In Central and Western Asia (Figure 12), adult deaths from non-communicable 
diseases represent the major killer, according to WHO estimates. Countries that belong 
to this group are Azerbaijan, Tajikistan, Turkmenistan, Uzbekistan and Yemen. HIV 
and AIDS, and TB-related deaths occupy the largest share in Tajikistan.  
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Figure 13. Distribution of adult deaths by major cause (%), Central and Western Asia 
Authors’own calculations based on WHO 2011 data.  
3.3 Adult Mortality in Other Countries: Latin America and Oceania 
Two Latin American countries, Bolivia and Haiti, fall within our classification criteria 
(Figure 10b). UN estimates of adult mortality for Bolivia indicate a downward trend 
while siblings estimates are substantially lower.  
In Bolivia, the burden of adult deaths can be largely attributed to non-
communicable and injury deaths, which seem to predominate. In Haiti, social conditions 
deteriorated in recent years due to failure of the state and the lack of capacity to cope 
with the existing humanitarian crisis, generated by the aid embargo and coupled by the 
health care system failure The WHO data portrays a large share of adult deaths due to 
infectious and parasitic diseases. 
Turning to the selected countries in the Oceanian region, i.e. Micronesia and 
Papua New Guinea (Figure 10b), UN adult mortality estimates present a stalled trend 
for Micronesia; UN estimates for Papua New Guinea, indicate a downward trend 
instead. In the latter country, the breakdown by cause of death (Figure 14) shows that 
communicable diseases,particularly infectious disease including HIV and TB, account 
for a large share of the estimates, followed by non-communicable diseases. The burden 
of non-communicable diseases is instead predominant in Micronesia.  
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Figure 14. Distribution of adult deaths by major cause (%), for selected countries in 
Latin America and Oceania. 
Authors’own calculations based on WHO 2011 data.  
 
Table 2. Probabilities of dying between ages 5 and 60, disaggregated by sex, from the 
2010 Revision of the World Population Prospects and estimates based on siblings 
histories collected in DHS.  
 Males Females 
Country DH
S 
199
8 
DH
S 
200
3 
DH
S 
200
8 
UN 
199
8 
UN 
200
3 
UN 
200
8 
DH
S 
199
8 
DH
S 
200
3 
DH
S 
200
8 
UN 
199
8 
UN 
200
3 
UN 
200
8 
  Central and Western Asia 
Azerbaijan    0.2
4 
0.2
1 
0.1
9 
   0.1
2 
0.1
2 
0.0
9 
Tajikistan    0.2
7 
0.2
6 
0.2
4 
   0.1
5 
0.1
5 
0.1
4 
Turkmenistan    0.3
1 
0.3
1 
0.3
1 
   0.1
7 
0.1
7 
0.1
6 
Uzbekistan    0.2
5 
0.2
5 
0.2
4 
   0.1
4 
0.1
4 
0.1
4 
Yemen    0.3
1 
0.2
7 
0.2
4 
   0.2
6 
0.2
3 
0.2
0 
  South-East Asia 
Cambodia 0.3
0 
0.2
6 
0.2
2 
0.3
3 
0.3
1 
0.2
7 
0.2
3 
0.2
0 
0.1
6 
0.2
9 
0.2
8 
0.2
4 
Lao PDR    0.2
9 
0.2
6 
0.2
2 
   0.2
4 
0.2
1 
0.1
8 
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 Males Females 
Country DH
S 
199
8 
DH
S 
200
3 
DH
S 
200
8 
UN 
199
8 
UN 
200
3 
UN 
200
8 
DH
S 
199
8 
DH
S 
200
3 
DH
S 
200
8 
UN 
199
8 
UN 
200
3 
UN 
200
8 
Myanmar    0.2
8 
0.2
6 
0.2
5 
   0.2
3 
0.2
2 
0.2
0 
Timor-Leste 0.2
1 
0.1
7 
0.1
4 
0.3
5 
0.3
0 
0.2
7 
0.2
4 
0.2
0 
0.1
6 
0.3
1 
0.2
7 
0.2
4 
  Southern Asia 
Afghanistan 0.2
3 
0.1
9 
0.1
5 
0.4
5 
0.4
3 
0.4
2 
0.2
0 
0.1
7 
0.1
4 
0.4
2 
0.4
0 
0.3
9 
Bangladesh 0.2
1 
  0.1
8 
0.1
8 
0.1
7 
0.1
8 
  0.1
8 
0.1
6 
0.1
5 
Bhutan    0.2
9 
0.2
4 
0.2
2 
   0.2
4 
0.2
0 
0.1
7 
India    0.2
8 
0.2
7 
0.2
6 
   0.2
2 
0.2
0 
0.1
8 
Nepal 0.2
1 
0.1
9 
 0.2
8 
0.2
4 
0.2
0 
0.2
0 
0.1
8 
 0.2
6 
0.2
2 
0.1
7 
Pakistan    0.2
1 
0.2
0 
0.1
9 
   0.1
8 
0.1
7 
0.1
6 
  Latin America 
Bolivia 0.1
9 
0.1
8 
 0.2
6 
0.2
5 
0.2
4 
0.1
7 
0.1
6 
 0.2
0 
0.1
9 
0.1
8 
Haiti 0.2
8 
0.2
9 
 0.3
1 
0.3
1 
0.2
8 
0.3
2 
0.3
5 
 0.2
7 
0.2
8 
0.2
5 
  Oceania 
Kiribati              
Micronesia    0.2
0 
0.1
9 
0.1
9 
   0.1
8 
0.1
7 
0.1
6 
Papua New Guinea    0.3
9 
0.3
6 
0.3
3 
   0.3 0.2
8 
0.2
5 
  Middle and Northern Africa 
Angola    0.4
5 
0.4
2 
0.4
0 
   0.4
0 
0.3
7 
0.3
5 
Cameroon 0.3
9 
0.4
1 
0.3
9 
0.3
9 
0.4
3 
0.4
3 
0.3
2 
0.3
2 
0.3
1 
0.3
5 
0.3
9 
0.4
0 
Central African 
Republic 
   0.5
1 
0.5
4 
0.5
1 
   0.4
5 
0.5
0 
0.4
8 
Chad 0.3
2 
0.3
4 
 0.3
6 
0.3
9 
0.3
8 
0.2
6 
0.2
4 
 0.3
0 
0.3
3 
0.3
3 
Congo 0.5
1 
0.4
4 
 0.3
9 
0.3
8 
0.3
5 
0.3
8 
0.3
2 
 0.3
5 
0.3
5 
0.3
2 
DR Congo 0.3
3 
0.3
6 
 0.4
4 
0.4
2 
0.4
2 
0.2
5 
0.2
8 
 0.3
9 
0.3
8 
0.3
6 
Equatorial Guinea    0.3
9 
0.3
9 
0.3
9 
   0.3
3 
0.3
4 
0.3
4 
Gabon 0.4
3 
  0.2
9 
0.3
2 
0.3
0 
0.2
5 
  0.2
5 
0.2
9 
0.2
7 
São Tomé and P.    0.2
5 
0.2
5 
0.2
4 
   0.2
1 
0.2
1 
0.2
0 
Sudan (Former Sudan)    0.3
4 
0.2
9 
0.2
8 
   0.2
8 
0.2
4 
0.2
2 
  Western Africa 
Benin 0.2 0.3  0.3 0.3 0.3 0.2 0.2  0.3 0.3 0.2
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200
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UN 
200
3 
UN 
200
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9 1 8 7 4 2 1 0 0 9 
Burkina Faso 0.3
5 
0.3
1 
0.2
5 
0.3
9 
0.3
6 
0.3
1 
0.2
6 
0.2
5 
0.2
3 
0.3
2 
0.3
0 
0.2
6 
Côte d'Ivoire 0.4
1 
0.4
8 
 0.4
3 
0.4
5 
0.4
1 
0.2
9 
0.3
3 
 0.3
8 
0.4
2 
0.3
8 
Gambia    0.3
4 
0.3
2 
0.3
1 
   0.2
8 
0.2
7 
0.2
6 
Ghana 0.2
7 
0.2
9 
 0.3
0 
0.3
0 
0.2
7 
0.2
4 
0.2
5 
 0.2
7 
0.2
7 
0.2
4 
Guinea 0.2
8 
0.3
3 
 0.4
2 
0.4
0 
0.3
7 
0.2
7 
0.3
2 
 0.3
7 
0.3
5 
0.3
2 
Guinea-Bissau    0.4
4 
0.4
3 
0.4
2 
   0.3
8 
0.3
8 
0.3
7 
Liberia 0.2
2 
0.2
8 
 0.4
9 
0.4
4 
0.3
8 
0.2
3 
0.3
0 
 0.4
3 
0.3
9 
0.3
4 
Mali 0.2
7 
0.2
5 
 0.4
2 
0.4
0 
0.3
7 
0.3
2 
0.2
9 
 0.3
5 
0.3
3 
0.3
1 
Mauritania    0.3
1 
0.3
0 
0.3
0 
   0.2
4 
0.2
3 
0.2
3 
Niger 0.2
4 
0.2
3 
 0.3
8 
0.3
5 
0.3
3 
0.2
4 
0.2
3 
 0.3
4 
0.3
1 
0.2
8 
Nigeria 0.2
8 
0.2
8 
 0.4
5 
0.4
4 
0.4
1 
0.2
6 
0.2
7 
 0.4
1 
0.4
0 
0.3
8 
Senegal 0.2
4 
0.2
3 
0.2
3 
0.3
3 
0.3
1 
0.3
0 
0.1
7 
0.1
7 
0.1
6 
0.2
8 
0.2
6 
0.2
5 
Sierra Leone 0.2
6 
0.3
1 
 0.5
9 
0.5
5 
0.4
8 
0.2
2 
0.2
7 
 0.5
5 
0.5
2 
0.4
6 
Togo    0.3
5 
0.3
6 
0.3
6 
   0.3
0 
0.3
1 
0.3
1 
  Eastern Africa 
Burundi 0.6
5 
0.4
6 
0.3
1 
0.4
8 
0.4
7 
0.4
4 
0.5
4 
0.3
7 
0.2
4 
0.4
3 
0.4
3 
0.4
0 
Comoros    0.3
2 
0.3
1 
0.2
9 
   0.2
7 
0.2
6 
0.2
5 
Djibouti    0.3
7 
0.3
6 
0.3
4 
   0.3
2 
0.3
2 
0.3
0 
Eritrea    0.4
5 
0.4
0 
0.3
7 
   0.3
6 
0.3
2 
0.2
8 
Ethiopia 0.4
1 
0.3
6 
0.2
4 
0.3
9 
0.3
7 
0.3
2 
0.3
7 
0.3
3 
0.2
2 
0.3
4 
0.3
2 
0.2
8 
Kenya 0.3
8 
0.4
2 
 0.4
2 
0.4
7 
0.4
1 
0.3
3 
0.3
6 
 0.3
8 
0.4
4 
0.3
9 
Madagascar 0.2
8 
0.2
8 
 0.3
0 
0.2
6 
0.2
2 
0.2
5 
0.2
6 
 0.2
6 
0.2
1 
0.1
8 
Malawi 0.5
7 
0.5
9 
0.4
9 
0.5
0 
0.5
3 
0.4
5 
0.5
4 
0.5
2 
0.4
0 
0.4
5 
0.5
1 
0.4
4 
Mozambique 0.3
9 
  0.4
6 
0.4
9 
0.5
0 
0.2
7 
  0.3
8 
0.4
2 
0.4
5 
Rwanda 0.6
7 
0.4
0 
0.3
1 
0.5
4 
0.4
3 
0.3
6 
0.5
7 
0.2
9 
0.1
8 
0.5
0 
0.4
0 
0.3
2 
Somalia    0.4
1 
0.3
8 
0.3
8 
   0.3
5 
0.3
3 
0.3
2 
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S 
199
8 
DH
S 
200
3 
DH
S 
200
8 
UN 
199
8 
UN 
200
3 
UN 
200
8 
Uganda 0.5
1 
0.5
2 
0.4
4 
0.5
4 
0.5
0 
0.4
2 
0.4
3 
0.4
2 
0.3
2 
0.4
9 
0.4
8 
0.4
1 
United Republic of 
Tanzania 
0.4
2 
0.3
9 
0.3
4 
0.4
5 
0.4
5 
0.4
0 
0.3
6 
0.3
5 
0.3
2 
0.4
1 
0.4
2 
0.3
8 
Zambia 0.6
0 
0.6
5 
 0.6
0 
0.6
1 
0.5
0 
0.5
6 
0.6
0 
 0.5
6 
0.6
0 
0.5
0 
Zimbabwe 0.5
9 
0.6
8 
0.6
2 
0.5
8 
0.6
8 
0.6
2 
0.5
0 
0.6
0 
0.5
5 
0.5
5 
0.6
9 
0.6
6 
  Southern Africa 
Botswana    0.4
4 
0.5
8 
0.5
1 
   0.4
0 
0.5
7 
0.5
4 
Lesotho 0.5
0 
0.7
2 
0.7
3 
0.4
4 
0.6
2 
0.6
0 
0.3
7 
0.5
8 
0.6
0 
0.4
0 
0.6
1 
0.6
2 
Namibia 0.5
0 
0.6
1 
 0.3
5 
0.4
2 
0.3
5 
0.3
4 
0.4
7 
 0.3
0 
0.4
0 
0.3
4 
South Africa    0.4
2 
0.5
3 
0.5
5 
   0.3
1 
0.4
6 
0.5
2 
Swaziland 0.5
2 
0.7
1 
 0.4
4 
0.5
9 
0.5
7 
0.4
3 
0.6
1 
 0.4 0.5
7 
0.5
7 
Note: Estimates referring to DHS data are based on authors' computations. 
4 Forces Affecting the Future of Mortality in High Mortality Countries  
Over the past 50 years, mortality changes in high mortality countries have varied 
considerably, sometimes with major and rapid declines, sometimes with slow but 
regular declines, sometimes with stagnations, and occasionally with major increases. 
The determinants of these changes are complex, and can be studied at various levels. 
The following sections review the literature on forces affecting the future course of 
mortality, with particular reference to those aspects relevant to high mortality 
populations. In assessing the capability of specific forces to substantially affect future 
trends in child mortality, it is important to bear in mind that, as childhood mortality 
declines, infant mortality as a share of childhood mortality increases, especially 
mortality during the first month after birth. By 2010, half of all deaths under age five 
occurred to neonates in South Asia, and in sub-Saharan Africa the neonatal share of 
child mortality was 30 percent.  
4.1 HIV and AIDS4  
The AIDS epidemic is considered the most important factor affecting survival prospects 
of adults and children in most of the high mortality countries. The future of HIV and 
AIDS rests primarily on hope for development of a preventive vaccine that is “safe, 
simple, highly effective and affordable” (Hemelaar et al. 2006: 2). However, the 
effectiveness of a global vaccine is threatened by the genetic and antigenic variability of 
                                                 
4
 Portions of this section draw partly on  publications of the United Nations, Department of Economic and 
Social Affairs, Population Division: World Mortality Report 2011 (2012) and World Population 
Prospects, The 2010 Revision: Highlights and Advance Tables (United Nations 2011c). 
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the virus (HIV-1). Impact of antiretroviral therapy and viral drug resistance are also 
important factors that could determine the future of the pandemic (Mahy et al. 2010). 
Beside the ABC strategy, which promotes abstinence, being faithful, and condom use 
and therefore safer behaviours the most effective intervention coming as close to a 
lifetime effective protection similar to a vaccine has been found to be circumcision 
(about 60% effectiveness based on randomized trials) (Auvert et al. 2005). 
According to the most recent epidemic update by UNAIDS (2010), the overall 
growth of the HIV epidemic seems to have stabilized: the annual number of new HIV 
infections has been declining since the 1990s. In addition, the number of AIDS deaths 
has also been decreasing, a consequence of the scale-up of antiretroviral treatment 
(ART), resulting in an increasing trend in prevalence (defined as all currently infected 
individuals). In sub-Saharan Africa, where the epidemic has been particularly severe, 
UNAIDS estimated the number of new infections in 2009 at 1.8 million, lower than the 
previous 2.2 million estimated for 2001. Five countries, Botswana, South Africa, 
Tanzania, Zambia and Zimbabwe, have shown a significant decline in new infections 
among young men and women according to national surveys, a decline largely 
attributed to changes in sexual behavior.  
In a recent paper, Bongaarts et al.(2011), present trends in AIDS mortality from 
1980 to 2030 using the UNPD estimates and projections. According to the authors, 
nearly all of the epidemics have reached their plateau, a consequence of both behavioral 
change and the natural course of the epidemic (i.e. saturation of high risk groups, as 
well as decline in the average infectiousness of individuals because fewer are in the 
post-infection state, or because of higher levels of ART). 
According to UNAIDS, an estimated 33.3 million people in the world were 
living with HIV in 2009 (UNAIDS 2010). In the 2010 Revision of the World Population 
Prospects, the demographic impact of the HIV/AIDS epidemic was explicitly taken into 
account when estimating and projecting mortality levels in 48 countries. Figure 15 
shows the estimated and projected number of deaths due to AIDS for selected groups of 
countries or regions based on those 48 countries (values are per five-year period). These 
countries, together, account for a substantial portion of all AIDS-related deaths in the 
world, but the numbers shown here should not be taken as estimates for the world. For 
these countries as a whole and, particularly for the sub-Saharan countries, a sharp 
increase in number of AIDS-related deaths took place beginning in the mid-1980 and 
continuing to 2000. From that point on, the number of deaths plateaued at about nine 
million deaths per quinquennium, with a peak of 9.4 million for the period 2005-2010. 
During the projection period, the total number of deaths is expected to decline slightly 
and subsequently increase slowly to about 10 million in 2045-2050. This projected 
increase is driven partly by population growth, but also by some of the assumptions 
made regarding parameters of the epidemic simulation model, and the treatment 
coverage (see discussion below). Cohort effects are also at play. Out of the 48 countries 
for which the impact of HIV/AIDS epidemic was explicitly incorporated in the 
mortality estimates, 37 are in sub-Saharan Africa, three are in Asia (including both 
China and India), and eight pertain to other regions of the world. The vast majority of 
AIDS-related deaths occur in sub-Saharan Africa, and the share of AIDS-related deaths 
in that region is projected to rise from about 76 percent in 2010-2015 to about 90 
percent in 2045-2050 (United Nations, 2012). In the three Asian countries, the number 
of AIDS-related deaths is expected to decline. 
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Figure 15. Estimated and projected number of deaths due to AIDS by region, per 
quinquennium, 48 AIDS-affected countries, 1980-2050 
Considering that some assumptions made about parameters of the epidemic 
simulation model and the treatment coverage partly determine future trends, it is 
important to discuss some of these assumptions. As noted in the United Nations 
Mortality Report (2012, p.30)  
Beginning in 2009, the parameter PHI, which reflects the rate of recruitment of new 
individuals into the high-risk or susceptible group, is projected to decline by half every 
twenty years. The parameter R, which represents the force of infection, is projected to 
decline by half every thirty years. The reduction in R reflects the assumption that 
changes in behavior among those subject to the risk of infection, along with increases in 
access to treatment for those living with HIV, will reduce the chances of HIV 
transmission.  
Also, coverage levels of interventions to prevent transmission of HIV from 
mother to child were projected in the 2010 Revision to reach, on average, 74 percent by 
2015 among the affected countries, varying between 40 per cent and 95 percent. After 
2015, the coverage is assumed to remain constant at the level reached in each of the 
affected countries in 2015. Furthermore, according to the UN report, “the 2010 Revision 
incorporates a revised survival for persons receiving treatment with highly active 
antiretroviral therapy. The proportion of the HIV-positive population receiving 
treatment averaged 64 percent in 2009 among the 48 affected countries" (United 
Nations 2012: 30). The proportion is projected to reach an average of 84 percent in 2015 
while ranging between 40 percent and 99 percent at the country level. Coverage levels 
are assumed to remain constant thereafter. For further details regarding the assumptions, 
we refer readers to United Nations publications (2012; 2011b). 
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While looking at the same total number of AIDS-related deaths, this time broken 
down by broad age groups (Figure 16), it can be said that AIDS mortality 
predominantly affects the "adult" population at ages 15-59. "Since the turn of the 
millennium, about 85 percent of all AIDS deaths in those 48 countries have occurred at 
ages 15-59 and that proportion is expected to only slightly increase by 2045-2050" 
(United Nations 2012: 31). As for children under the age of 15 who die from AIDS-
related causes, a decline in both absolute and relative terms is anticipated in the 
following decades. When taking into account the recent achievements that were made 
with respect to the reduction in mother-to-child transmission of HIV, one could expect 
even sharper reductions in the number of AIDS-related deaths of children (United 
Nations, 2012).  
Figure 16. Estimated and projected number of deaths due to AIDS by broad age groups, 
per quinquennium, 48 AIDS-affected countries, 1980-2050 
Sources: (United Nations 2011b DEMOBASE extract (Special tabulations)) and (United 
Nations 2012)  
Note: The numbers of deaths due to AIDS are for five-year periods.  
 
Based on the results of the estimates and projections for the group of countries 
described above, it is quite evident that when doing mortality projections for countries 
affected by the HIV/AIDS epidemic, especially those with very high prevalence levels, 
one needs to adopt special procedures that take into account the current and future 
impact of HIV on mortality indicators. Clearly, the trajectories in the projected levels of 
life expectancy at birth, and other mortality indicators, should differ from those in non-
affected or very low HIV prevalence countries. Furthermore, considering the differential 
impact across age groups, the age patterns of mortality should also encompass distinct 
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mortality levels and patterns. In that regard, special attention should be given to 
countries with prevalence levels above 10 per cent, mainly in Southern and Eastern 
Africa. 
Again, based on the results of the 2010 Revision of the World Population 
Prospects, and while measuring the mortality impact of the HIV/AIDS epidemic by 
comparing the mortality between the medium variant (“with AIDS”) and the No-AIDS 
scenario (“without AIDS”) in 2010-2015, researchers can get a sense of the impact of 
HIV/AIDS on specific mortality indicators. For instance, based on this comparison, 
AIDS more than doubled the probability of dying between ages 15 and 60 in seven 
countries, namely in Botswana, Lesotho, Malawi, Namibia, South Africa, Swaziland 
and Zimbabwe. AIDS can also significantly increase mortality among children, 
especially in the absence of treatment. For the period 2010-15, the largest absolute 
impact in child mortality was estimated to be in Swaziland, where excess under-five 
mortality due to AIDS amounted to 20 deaths per 1,000 live births. The highest relative 
impact (33 percent) occurred in South Africa, where the competing risks from other 
causes are lower than in Swaziland. In all countries of the Southern African region, the 
relative impact on under-five mortality exceeded 25 percent. Outside the sub-Saharan 
African region, most countries have experienced absolute impacts on under-five 
mortality of five deaths per thousand or less, while the relative impact has exceeded 10 
percent in some countries with relatively low mortality (United Nations 2012). 
Consequently, the increased mortality among adults and children may translate 
into severe reductions in life expectancy at birth. The largest impact in 2010-2015 was 
found to be in Botswana, where life expectancy at birth was estimated to be 17 years 
lower in the medium variant than in the No-AIDS scenario. The loss in life expectancy 
due to AIDS was estimated to exceed 10 years in eight other countries, namely Lesotho, 
Malawi, Mozambique, Namibia, South Africa, Swaziland, Zambia and Zimbabwe, and 
was found to be between five and 10 years in seven other countries (Cameroun, Central 
Africa Republic, Côte d’Ivoire, Gabon, Kenya, Uganda, and the United Republic of 
Tanzania). The very high HIV prevalence levels encountered in Southern and Eastern 
African countries have not been found in other regions of the world, and thus the impact 
on life expectancy for other regions is lower (United Nations, 2012). 
For the reasons outlined above, the WIC/IIASA argument-based probabilistic 
population projections have adopted mortality forecasts where the medium scenario 
coincides with the UN/WPP 2010 medium variant up to 2050 for sub-Saharan Africa, 
Haiti, and Afghanistan. Details on the methodology can be found elsewhere (Garbero & 
Sanderson 2012). 
4.2 Changes to Biomedical Technology  
Another determinant of mortality trends is health technology (preventive and curative 
medicine), as well as population coverage. For instance, the development of vaccines 
against childhood diseases (measles, whooping cough, tetanus, poliomyelitis, 
pneumonia, etc.) was instrumental in controlling the targeted diseases in high mortality 
countries and reducing their mortality. However, the demographic impact was most 
visible when the vaccination campaigns reached the whole population and became 
sustained, especially after the major effort led by UNICEF and other international 
organizations that began in 1985. 
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The development of drugs had a huge impact on mortality. Drug development 
started after 1945 with antimalarial drugs and antibiotics, and more recently has seen the 
use of anti-retroviral drugs and numerous other new medicines. These drugs have 
strongly reduced mortality from malaria, bacterial diseases, and more recently 
HIV/AIDS. In the field of nutrition, major improvements were also made through the 
creation of new strategies for treating and preventing severe malnutrition. However, 
there remains a number of diseases for which treatments are ineffective. That is 
particularly true for many cancers and other non-communicable diseases.  
Changes in biomedical technology encompass a range of developments, each of 
which has the potential to substantially reduce mortality. These technology changes 
include the development of new drugs and vaccines and their associated delivery 
mechanisms and diagnostic tools, as well as improvements in medical techniques, 
health care management, and improved software and communication tools. Yet the 
promise and almost certain introduction of new biotechnology developments in the 
future must be tempered by acknowledgement of the barriers to technological 
innovation and implementation that exist in resource poor settings. Such barriers include 
deficiencies in both infrastructure (power, water, roads) and personnel (skilled 
technicians and practitioners), as well as public mistrust and competing priorities for 
even minimal resources (Malkin 2007). In the past, financial incentives for developing 
biomedical technology appropriate for resource-poor populations have come 
predominantly from wealthier countries – either governments or private foundations – 
and the extent to which this will be necessary in the future is likely to differ 
dramatically across the current high mortality countries. Large countries, such as India 
with its substantial highly trained research and technical workforce, have already 
demonstrated the capability to generate appropriate new biomedical technologies. 
Smaller countries with fewer trained personnel are less likely to develop this capacity 
(Coloma & Harris 2004). 
An international focus on reducing childhood mortality, with a recent emphasis 
on improving both maternal and newborn outcomes during delivery and immediately 
post-partum, might provide the impetus needed to bring important changes in medical 
care and treatment to resource-poor areas. Examples of technological innovations that 
show promise include: treatment of postpartum hemorrhage with misoprostol or pre-
packaged injectable oxytocin (Buekens & Althabe 2010; Winikoff et al. 2010), use of 
antenatal steroids to prevent death associated with premature delivery (Mwansa-
Kambafwile et al. 2010), use of chlorhexidine to prevent umbilical cord infections 
(McClure et al. 2007), administration of antiretroviral treatment to prevent mother-to-
child transmission of HIV/AIDS, new pneumococcal and rotavirus vaccines, and remote 
imaging from rural health clinics. 
4.3 Effectiveness of Health Care Systems 
All of the high mortality countries have relatively high levels of both maternal mortality 
and neonatal mortality. These two adverse outcomes are strongly linked, and their levels 
reflect the effectiveness of health care systems. A country’s overall health system and 
the number of health personnel in particular are key determinants of mortality decline. 
Countries with a high proportion of physicians per capita have low mortality, as 
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Botswana before 1990. In contrast, when physicians leave the country, mortality tend to 
rise, as in Ghana between 1978 and 1983 (Garenne 2010a). 
As child mortality declines, neonatal mortality will assume a larger share of the 
remaining mortality burden. Reducing neonatal mortality will depend on improving and 
increasing access to antenatal care, skilled birth attendants, and available care for 
complications arising during pregnancy and delivery. Data from the Demographic and 
Health Surveys around 2008 indicate that the percent of births attended by a skilled 
provider varied considerably over the high mortality countries, from less than 25 
percent in Bangladesh, Nepal and Lao PDR to almost 100 percent in Turkmenistan 
(World Health Organization 2010).  
Efforts to increase access to skilled health providers for delivery have been both 
numerous and varied in these countries, especially over the past decade. Increases in 
institutional deliveries occurred in both Ghana and Rwanda after government initiatives 
to reduce user fees as a barrier by paying providers directly for services and, in the case 
of Rwanda, to improve the quality of service provided. Other countries have focused on 
upgrading the skills of traditional midwives or providing incentives for private doctors 
to deliver services in underserved areas (World Health Organization 2010). The 
successes and failures of these various programs can guide future health systems 
investments in other high-mortality countries where health care resources are limited. 
However, progress toward cost-effective rationalization of reproductive health services 
delivery is hampered by a lack of data on the current level and quality of services 
provided.  
4.4 Behavioural Changes Related to Health  
Behavioural changes related to health are also important determinants of mortality 
especially related to the rise of non-communicable diseases in developing countries.  
With respect to nutrition, the quantity and quality of the diet has generally 
improved over the past 50 years, which has had an impact on the mortality of children 
and adults. There are exceptions to the overall improvement, especially in Africa, which 
has been plagued with political turmoil, wars, and extensive government 
mismanagement. And while people in much of the developing world struggle to get 
enough food, the problem of obesity is emerging in Southern Africa, especially among 
women. The problem is linked not only to consuming too much food, but eating 
unhealthy food (e.g. some industrially-produced products) as well as diets based on 
fried food and saturated fat. Economic and social changes are typically accompanied by 
changes in health behaviours, especially with respect to hygiene, disease prevention, 
and use of appropriate health services when sick. However, economic and social change 
is sometimes associated with negative behaviours, such as smoking, substance abuse, 
lack of physical exercise, and risky sexual behaviour. These behaviours can lead to 
significant increases in mortality from cancers and other non-communicable diseases. 
4.5 Other Infectious Diseases: Role of Neglected and Emerging Diseases 
In the 1960’s, the widely held belief around the globe was that infectious diseases were 
under control in terms of prevention and treatment and that their effect on mortality 
would become negligible. Since that time, a number of diseases have emerged or re-
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emerged, sometimes with significant impacts on mortality levels and trends. The WHO 
defines an emerging disease as, “one that has appeared in a population for the first time, 
or that may have existed previously but is rapidly increasing in incidence or geographic 
range.” 
The dynamics of such diseases are largely independent of economic 
development, level of education, or socioeconomic status, and are almost impossible to 
predict. They are determined by a variety of factors, including: evolutionary factors 
(jumping the species barrier); natural selection (pressure of antibiotics or other drugs); 
ecological factors (appearance of a new niche or a new vector); demographic factors 
(population density, migration); and behavioural factors (e.g. sexual behaviour). The 
mortality impact of these diseases depends on their spread in general populations, their 
lethality, their latency period (e.g. the length of the asymptomatic phase) and the 
absence of prevention or treatment. The NIAID lists around 20 recent emerging / re-
emerging diseases, and more are likely to come in the future. 
Among the emerging / re-emerging diseases in the past 40 years in high 
mortality countries, three stand out as having a major mortality impact: HIV/AIDS, 
tuberculosis, and malaria. HIV/AIDS started to spread in general populations in the 
early 1980’s and soon became a leading cause of death among young adults and 
children. The disease was almost always lethal for the first 20 years of the epidemic. 
The course of the epidemic changed in about 2000, when prevention efforts (condom 
use and reducing casual partners) came into effect. Since that time HIV prevalence has 
stabilized and tended to decline in most infected countries. Its mortality impact changed 
radically at about the same time, with the massive use of antiretroviral therapy (ARV). 
Even in highly infected countries such as South Africa, mortality started declining after 
years of increase. South Africa experience 15 years of increases in mortality before a 
decline began in 2005 that was the start of a fast-paced new trend.  
Emerging diseases such as HIV/AIDS have not only an impact on mortality 
from infectious diseases, but also on non-communicable diseases (cancers), and even on 
maternal mortality. For instance, in South Africa, indirect causes of maternal deaths 
increased four-fold because of HIV and tuberculosis, and direct causes increased two-
fold, partly because of the diseases themselves (causing puerperal infections), and partly 
because ARV treatments induced hypertension, causing death by eclampsia. 
Tuberculosis also re-emerged in a number of places for two reasons: first, it is an 
opportunistic infection of HIV/AIDS, so the HIV/AIDS epidemic induced a large 
increase in the number of tuberculosis cases. Second, the use of antibiotics was so 
extensive that it led to an increase in resistant strains of diseases, which increased their 
lethality. In recent years, however, new combination treatments are bringing the disease 
under control.  
Malaria re-emerged in Africa in the 1980s and 1990s, mostly as a result of the 
pressure of treatment with chloroquine, leading to massive resistance and increased 
mortality (Trape 2001). However, since 2000, the disease is again on the path to be 
controlled, in part because of new and more efficient treatments (in particular with 
Artemisinin combination therapy), and due to new prevention efforts, particularly 
insecticide impregnated bed nets.  
Infectious agents for a host of diseases, such as influenza, meningitis, and 
diarrheal diseases, are constantly evolving and responding to drugs by developing 
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resistance. As a result, the long-term effect of these diseases on mortality can only be 
estimated with a large degree of uncertainty.  
4.6 Environmental Changes 
The impact of climate change on human life and health is an area of intense scientific 
scrutiny. The pathways through which climate change may affect health and mortality 
can be partitioned into four broad groups: 1) increased frequency and intensity of heat 
waves, floods, and droughts e.g. climate stress; 2) a reduction in cold-related deaths; 3) 
changes in the distribution of vector-borne and infectious diseases, and 4) increased 
risks of disasters and malnutrition (Haines et al. 2006). The overall balance across these 
factors is likely to be negative with populations in developing countries likely to be 
greatly affected by the adverse impacts of climate change. For instance, the direct 
impacts will result in changes in water distribution and agricultural production, 
including food. Rising temperatures leading to changes in the distribution of vector-
borne diseases are believed to be responsible for changes in the incubation period of the 
pathogen within the vector, resulting in increased risks of malaria, Dengue fever, Lyme 
disease, and Ross River Virus (Strand et al. 2010). The evidence shows that high-
income countries are also likely to be affected, with possible examples being the 2003 
heat wave in Europe, hurricane Katrina in the US in 2005, and the Melbourne bushfires 
in 2009. Indirect impacts of rising temperature include increased sea level and ocean 
acidity. 
Public-health strategies and improved surveillance are essential to improve 
adaptation to climate change especially in low income countries. Reducing the use of 
fossil fuels and increasing the use of renewable energy technologies should improve 
health in the near term by reducing exposure to air pollution and therefore mitigate the 
negative impacts of climate change (McMichael et al. 2004; Tanser et al. 2003; World 
Health Organization 2006). 
4.7 Mortality Due to Crises5 
The political stability of the state, or national government, and its investment in the 
health sector are likely to be key ingredients of a positive transition to low mortality. 
Conversely, political instability often leads to an increase in mortality. An example of 
the first scenario is Senegal, a country with virtually no economic growth and a low 
level of education, which yet has experienced a dramatic decline in under-five mortality 
since 1960. A counter example is Uganda, where a major political crisis induced by a 
coup d’état in the 1970s and years of civil war, led to a large increase in mortality 
(Garenne & Gakusi 2006).  
Crises resulting from conflicts, violence, famine or natural disasters (including 
tsunamis, earthquakes, floods and hurricanes, etc.) may not only lead to overall 
increases in mortality, but also affect segments of the population in ways that may 
translate into distinct patterns of excess mortality by age and sex. Excess deaths from 
                                                 
5
 Portions of this section are partly drawn upon from United Nations (2011a) 
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these crises can be caused directly by violence or natural disasters, but may moreover be 
associated with indirect effects, such as damage to infrastructure, interruption of 
services (water, sanitation, health care), and harm to production and marketing of food. 
Consequently, mortality risks may continue to be higher after the period of an actual 
crisis. Furthermore, crisis-induced morbidity and malnutrition could also have long-
term negative effects on the health and mortality of a given population. 
Such crises can lead to important deviations in the trend of mortality decline that 
is considered typical in most projections of mortality levels and therefore need to be 
taken into account while doing such an exercise. Though it is clear that many different 
types of crises will occur in the following decades, predicting such events in specific 
geographic settings is not feasible. However, our knowledge of current crises and post-
conflict situations can be taken into account when generating feasible assumptions 
regarding short- or medium-term projections of mortality decline. Clearly, countries that 
are now in the midst of a crisis should be subject to different patterns than countries that 
have recently faced one. On the one hand, the projected increase in life expectancy at 
birth should be more conservative in a country that is currently in the midst of conflict 
or civil strife. Such considerations should be taken into account for countries like 
Afghanistan, Somalia, Sudan, and Syria. On the other hand, a country that has recently 
come out of a severe crisis may be experiencing outstanding progress in mortality 
declines and researchers should be cautious in extrapolating the resulting trends into the 
future. For example, Rwanda, a country that experienced tremendous mortality spikes in 
the mid-1990s due to the genocide and other crises has been experiencing exceptional 
declines in mortality, partly as a result of the recovery one would anticipate following a 
mortality shock.  
Outside interventions following a shock can benefit the survival prospects of 
populations. Though it is not easy to measure precisely the role of each event (recovery 
vs. interventions), it is clear that the outcome of such a unique combination of events 
should not be extrapolated into the future; the pace of decline in mortality is likely to 
slow down. Furthermore, not all countries that have undergone a mortality crisis due to 
a conflict, civil strife, or other events have experienced fast declines in mortality in the 
aftermath of the crisis. Following a crisis, government capabilities to make proper 
interventions are sometimes limited or compromised, which may result in slow progress 
in survival improvements. The same may apply to countries that have been facing long 
term crisis. One could anticipate, for the following years, slow improvements in the 
level of life expectancy at birth, if any, in countries that are no longer in the midst of a 
crisis but are still facing economic and other challenges. 
4.8 Differential Trends in Population sub-Groups  
This section briefly reviews important relationships between a variety of causes and 
conditions, on the one hand, and mortality trends in particularly affected populations, on 
the other. Economic development and income per capita are important determinants of 
mortality decline, and periods of economic growth are usually associated with the latter, 
whereas periods of economic crises are often associated with increased mortality. An 
example of the first scenario is Gabon before 1990, a relatively wealthy country that 
reached relatively low levels of mortality. A counter example is Zambia, which has 
been ruined by an economic crisis that struck in 1975 and led to a major increase in 
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mortality. Higher household income also has a direct effect on health through improved 
nutrition, causing major declines in income to be associated with  worsening nutritional 
status (Waltisperger & Meslé 2007). 
Pockets of extreme poverty have emerged in numerous large cities, with serious 
health consequences. For instance, in the slums of Nairobi, Kenya, under-five mortality 
has doubled over the past 20 years because of badly inadequate hygiene conditions, 
violence, and lack of infrastructure and personnel (Garenne 2010b). 
A high level of education at the national and household levels is usually 
associated with lower mortality because education is closely associated with knowledge, 
attitudes, and behaviours, all determinants of a person’s health status. 
Familial socioeconomic status has been found through extensive research to be a 
primary determinant of infant and child survival across virtually all societies, regardless 
of the overall standard of living. In addition, the independent effect of maternal 
education on infant and child survival has received special consideration beginning with 
the pioneering work of John Caldwell (1979). While the majority of empirical research 
has shown a strong, independent effect of maternal education on family economic 
resources, variation in the strength of this effect has been observed across countries and 
over time. Recent research has demonstrated that some of this variation may be due to 
the overall level of educational attainment of women at both the community and societal 
levels. Thus, as a higher proportion of women attain secondary or higher levels of 
education, infant and child survival appears to improve even for women with less 
education and fewer economic resources. In projecting the impact of sub-group 
differentials on future trends in infant and child mortality, the extent of social and 
economic integration across the country as a whole, and particularly between rural and 
urban areas, is likely to have a large influence on the rapidity of improvement in child 
survival (Pamuk et al. 2011).  
Evidence has shown that increasing levels of educational attainment are likely to 
be correlated with decreasing levels of mortality, morbidity and disability among adults 
(for a survey see KC & Lentzner 2010). In North America and Europe, the literature has 
documented the existence of an education gradient in mortality, specifically a strong 
inverse relationship between education and mortality among adults (Kunst & 
Mackenbach 1994; Ross & Mirowsky 2006; Ross & Mirowsky 1999; Zajacova 2006). 
The relevant literature outside of developed countries, particularly sub-Saharan 
Africa, is scarce. A few studies in Asia document the usual negative relationship, with 
some exceptions, primarily related to women’s survival and breast cancer mortality (KC 
& Lentzner 2010).  
In sub-Saharan Africa, where HIV and AIDS has been ravaging populations for 
the past 20 years, evidence of an education gradient in mortality is mixed, implying a 
high degree of heterogeneity, especially as far as the link between HIV infection and 
education is concerned (Fortson 2008). A number of authors (Gregson et al. 2001; Over 
& Piot 1993) have documented a positive relationship, particularly at the beginning of 
the epidemic, where highly educated individuals were more likely to engage in risky 
sexual behaviors given the availability of casual sex and the means to pay for it. Forston 
(2008) shows evidence in her recent paper of a robust positive education gradient in 
HIV infection, after controlling for a rich set of confounders and non-response bias in 
HIV testing, where adults with six years of schooling were more likely to be HIV 
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positive than adults with no education. Other authors (Glynn et al. 2004) found no 
evidence of an increased risk of HIV infection associated with education, hypothesizing 
that the more educated might be responding more adequately to behavioral change 
programmes.  
Based on an analysis of maternal mortality modules across 84 DHS surveys 
conducted in high mortality countries, Masquelier and Garbero (forthcoming) looked at 
educational differentials in adult mortality (defined as the probability of dying between 
ages 25-40) based on siblings estimates. The analyses were based on surveys conducted 
in high mortality countries such as in Sub-Saharan Africa (70 DHS), Haiti, Afghanistan, 
Bangladesh, Nepal, Cambodia, Timor-Leste, and Bolivia. In this study, the authors  
examined the relationship between the living sister level of educational attainment and 
adult deaths in the household. The critical assumption is that educational outcomes are 
correlated among siblings, therefore the level of educational attainment of the living 
sibling acts as a proxy for the level of educational attainment of the deceased sisters 
(Graham et al. 2004).  
The results confirm the large heterogeneity of country-specific trends by level of 
educational attainment particularly for those countries with several DHS and reliable 
adult mortality trends (namely Bolivia, Kenay, Madagascar, Namibia, Uganda, Rwanda, 
Zambia and Zimbabwe). This heterogeneity is both a function of the overall level of 
adult mortality and the stage and size of the HIV epidemic. Specifically, in countries 
with a relatively low level of adult mortality such as Bolivia and Madagascar, the 
negative expected gradient was found, i.e. significantly higher risks of dying for 
uneducated women versus those of women with lower secondary education or higher. In 
some of the remaining countries, an opposite gradient was found, although not 
statistically significant. Other countries presented instead an evolving gradient that 
highlights the important role of HIV as a confounding factor in the positive 
relationships between educational attainment and survival gains (Masquelier & Garbero 
2012). Further research using supplementary datasets should both aim at triangulating 
these results and also exploring the causal mechanisms that drive the relationship 
between education and mortality and lie behind such gradients. 
5 Expert Survey on the Future of Life Expectancy in High Mortality 
Countries 
This section presents the results of the 2011 survey module on future trends in life 
expectancy in high mortality countries. Survey respondents provided numerical 
predictions of future trends in life expectancy through 2050 and an assessment of 
factors producing these trends for a country of their choice. They were also asked to 
indicate additional countries or regions for which their assessment was valid. 
Altogether, only 28 questionnaires in the high mortality module of the survey were 
completed, with results pertaining to a total of 14 countries. The paucity of responses 
corroborates both the uncertainty that revolves around the estimation of mortality trends 
in high mortality countries and the lack of experts’ confidence in making predictions 
about the future of mortality in such countries. The following figures combine responses 
for all 14 countries in the high mortality questionnaire sample, (n=28), as well as for the 
10 countries of sub-Saharan Africa (n=17) and the four countries of South Asia (n=11) 
separately (Table 3). 
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Table 3. Survey respondents according to country and region of projection provided, 
country of work, field of expertise, gender and age. 
Country (and region of projection)  No. of experts  Country of work No. of experts 
Eastern Africa    
Kenya 1 Austria 1 
Malawi 1 Belgium 1 
Tanzania 1 Burkina Faso 3 
Uganda 1 Congo 2 
Zimbabwe 1 India 5 
Middle Africa  Kenya 1 
Cameroon  3 Lesotho 1 
Congo (Dem. Rep. of) 3 Nepal 1 
Southern Africa  Nigeria 2 
Lesotho 1 Pakistan 1 
Western Africa  South Africa 1 
Burkina Faso 3 Uganda 1 
Nigeria 2 United States 2 
South-Central Asia  Missing 6 
Bangladesh 1 Total 28 
India 8   
Nepal 1 Gender No. 
Pakistan 1 Female 6 
Total responses 28 Male 16 
 
 Missing 6 
Field of expertise  Total 28 
Data collection and analysis 1   
Demography 1 Age group No. 
Economics 1 20-24 1 
Epidemiology 1 25-29 2 
Fertility, Ageing, Reproductive health 1 30-34 2 
Health Economics 1 35-39 5 
Mortality 1 45-49 3 
Maternal and Childhood mortality 1 50-54 2 
Migration 3 55-59 3 
Migration and health 1 60-64 2 
Monitoring and Evaluation  1 65+ 1 
Population & health 1 Missing 7 
Population Studies 1 Total 28 
Population, FP, RH 1   
 37 
Country (and region of projection)  No. of experts  Country of work No. of experts 
Quantitative demography/projections 2   
Reproductive health and development 1   
Social demography 3   
Economic demography, fertility, health 1   
Reproductive health 1   
Missing  4   
Total 28   
 
One of the key elements of this exercise was to obtain predicted decadal gains in 
life expectancy at birth from respondents for 2010-2030 and 2030-2050 (“best guess” 
estimates plus 80 percent uncertainty intervals). After providing a numerical estimate 
for the decadal gain in life expectancy, experts were asked to assess the validity and 
relevance of alternative arguments about the forces (clusters) that will shape these future 
trends. Then, having worked through the arguments of the questionnaire, experts were 
asked whether they wanted to alter their initial projections. Most experts kept their 
projections unaltered. If the respondent did not alter the preset default value for the 
point estimate, minimum, or maximum, these responses were set to “missing”. The 
following figures show the experts’ final projections of life expectancy at birth, along 
with the official UN estimated trend since 1950 and projections revised in 2010 (United 
Nations, 2011). The gains in life expectancy for 2005-2020 and for the decade 2030-
2040 are derived from interpolating the decadal estimations related to the start of the 
period in 2005. The grey areas around the expert trend indicate the range of the 80 
percent uncertainty intervals assessed by the experts. The regional and global 
estimations were further weighted by the population sizes of the countries, based on UN 
data and medium variant prediction until 2050/55. For comparing the regional mortality 
trend of the experts with the UN estimation, we selected only those countries for which 
the experts assessed the future gain in life expectancy. 
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Figure 17. Previous and expected future trend in life expectancy at birth for 
all high mortality countries 
Note: Authors’ own calculations 
 
The gains in life expectancy since 1950 in these high mortality countries 
represent one of the major achievements of the latter half of the 20th century. Between 
1950 and 1975, the UN estimates that life expectancy at birth increased from 39 to 53 
years in these countries. However, the impact of the HIV/AIDS epidemic resulted in a 
dramatic slowing of the previous pace of improvement. Between 1975 and 2000, life 
expectancy at birth increased by only seven years. More recently the pace of 
improvement appears to have again accelerated slightly, with life expectancy at birth 
reaching 63.6 in 2010. The UN medium variant however, projects a future gain of only 
two years each decade between 2010 and 2050, implying life expectancy at birth of only 
72 years by mid-century. The experts responding to our survey were more optimistic, 
predicting decadal gains of over three years, implying a life expectancy at birth of 70.5 
in 2030 and 77.1 in 2050. Despite this general optimism, the range of uncertainty was 
quite high, with lower values representing only a three-year gain between 2010 and 
2050, and higher values indicating a 20-year gain.  
The survey respondents were also asked to assess the validity and relevance of 
alternative arguments about the forces that could shape future mortality trends in the 
country or region they chose. Survey respondents for high mortality countries were 
given a list of 39 arguments grouped according to seven underlying forces, forming the 
following clusters: changes in bio-medical technology; effectiveness of health care 
systems; behavioural changes related to health; infectious diseases and resurgence of 
old diseases; environmental change, disasters and wars; changes in composition and 
differential trends in population subgroups; and HIV/AIDS.  
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For each argument the experts could assess the likelihood, the conditional 
impact, and the net impact. The likelihood or validity of an argument was defined across 
the following response scale: Very likely wrong = 0; more likely wrong than right = 
0.25; ambiguous = 0.5; more likely right than wrong = 0.75; very likely right = 1.0. The 
conditional impact gives the respondents’ assessment regarding the consequences of the 
argument for future life expectancy, if the argument becomes true. The scale contains 
five categories: strongly decreasing (-1); moderately decreasing (-0.5); none (0); 
moderately increasing (0.5); strongly increasing (1). Likelihood and conditional impact 
were then used to derive an argument’s net impact on future life expectancy. In the 
survey, these net impacts were predefined as a combination (multiplication) of an 
argument’s likelihood and its conditional impact, but the experts were free to change the 
calculated impact. At the end of the questionnaire the experts could allocate points to 
each cluster of arguments based on its relative importance for future trends in life 
expectancy. Allocations were made so that the sum of distributed points totaled 100 
percent. 
Figure 18 shows the net impact of each argument in a Circos plot. Each segment 
of the plot presents one cluster, while the size of the segment depends on the cluster 
importance as assessed by the experts. The cluster of arguments deemed most important 
by the survey respondents related to the effectiveness of health care systems (24 percent 
importance), followed by behavioural changes related to health (17 percent importance) 
and changes in bio-medical technology (15 percent importance). However, the specific 
arguments having the greatest net impact on life expectancy in the high mortality 
countries under consideration were not necessarily in those clusters of forces deemed to 
have the greatest importance. Within each cluster, the net impact of individual 
arguments is shown in the outer grey ring. Arguments could be interpreted to have 
either a positive or negative influence on life expectancy, as indicated by the position of 
the bars. The optimism expressed by respondents in their numerical predictions for life 
expectancy at birth is reflected in the larger net impact values for arguments with 
positive influences compared with arguments with negative influence. 
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Figure 18. Circos Plot 
 
The average relative importance given to each cluster is shown on the left side of 
Figure 19, here indicated by the size of the circle. The position of the circle on the Y-
axis represents the absolute value of the argument with the highest net impact on future 
life expectancy within that cluster. 
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Figure 19. Cluster relevance and the ranking of highest impact arguments for all high 
mortality countries (Global trend) 
The right side of Figure 19 ranks specific arguments by multiplying the absolute 
value of their mean net impact score by the cluster weight. So although the argument 
“Improvements in the education of women will improve the health of children” (HD 6-
4) was assigned the highest net impact score of any specific argument, it is not ranked 
among the top five arguments. This is because overall, factors related to differential 
trends in population sub-groups are not considered to have as much impact on future life 
expectancy as other forces. By contrast, the importance allocated to the effectiveness of 
health care systems combined with relatively high net impact scores means that the four 
highest ranked arguments come from this cluster: basic public health interventions for 
children under five (HD 2-4), expansion of coverage for inexpensive interventions 
against diarrhoea, pneumonia and malaria (HD 2-5), extension of reproductive health 
services (HD 2-6), and investments in education increasing the quality of health care 
personnel (HD 2-8) , . 
As noted previously, the countries that continue to experience high mortality 
levels are concentrated in sub-Saharan Africa and Asia, with African countries 
disproportionately affected by the HIV/AIDS epidemic. We therefore examine the 
survey responses for African and Asian countries separately. 
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Figure 20. Previous and expected future trend in life expectancy at birth for Africa 
As shown in Figure 20, the increase in life expectancy at birth since 1950 has 
been less dramatic in the 10 African countries for which we obtained survey responses 
than for all 14 high mortality countries. In addition, the HIV/AIDS epidemic resulted in 
a decline in life expectancy between 1985 and 1995, but the recent resumption of 
continual improvement in survival has been quite dramatic. Still, by 2010 life 
expectancy at birth in these African countries was estimated to be only 53.6 years. 
The increase in life expectancy predicted by the survey respondents exceeded 
the UN projections only slightly; the UN medium variant projects a gain of 7.2 years for 
2010-2020 and a gain of 6.2 years for 2020-2050, while the survey respondents 
predicted, on average, gains of 8.1 years and 6.4 years for these same periods. However, 
the degree of uncertainty expressed by the survey respondents was substantial; the lower 
bound reflects in a decline in life expectancy of 4.6 years by 2050, while the upper 
bound indicates a gain of 23.4 years. 
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Figure 21. Cluster relevance and the ranking of highest impact arguments for Africa 
 
Figure 21 shows that survey respondents for African countries regarded a 
number of underlying forces as important in determining the future course of life 
expectancy: the effectiveness of health care systems (Cl 2, 26% influence), HIV/AIDS 
(Cl 7, 17% influence), changes to bio-medical technology (Cl-1, 16% influence), and 
behavioral changes related to health (Cl-3, 15% influence). With respect to specific 
arguments, “Improvements in the education of women will improve the health of 
children” (HD 6-4), and “Improvements in medical technology will contribute to 
declining mortality” (HD 1-1) were considered to have the greatest net impact on life 
expectancy. Still, the combination of the greater cluster weight and relatively high net 
impact scores given to specific arguments means that arguments related to the 
effectiveness of health care systems dominated the list of top five arguments for African 
countries (right side of Figure 21). 
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Figure 22. Previous and expected future trend in life expectancy at birth for Asia  
As shown in Figure 22, life expectancy at birth increased dramatically after 1950 
in the four populous Asian countries of India, Pakistan, Bangladesh and Nepal. The 
period between 1950 and 1975 saw an increase of 15 years, and even as the pace of 
increase slowed somewhat since 1975, life expectancy continued to rise by nearly 3.5 
years per decade, reaching 66 years by 2010. After 2010, the UN medium variant 
assumes a slowing in life expectancy gains in these four countries, projecting a decadal 
gain of only 2.5 years between 2010 and 2030 and a decadal gain of only 1.5 years 
between 2030 and 2050. The survey respondents for these countries were considerably 
more optimistic, expecting an average increase of 3.8 years per decade, producing a life 
expectancy at birth of 81.4 by mid-century. In addition, the level of confidence 
expressed for these predictions was substantially greater than for Africa. The upper 
bound indicates a gain of 21 years by 2050, resulting in life expectancy at birth reaching 
87.2 years. It is interesting to note that the lower confidence bound given by survey 
respondents indicated a pattern and level of life expectancy gain only slightly less than 
the UN medium variant projection, resulting in a projected life expectancy for 2050 of 
73.5 years, while the UN projection is for life expectancy to reach 74.6 years. 
Another difference is that respondents for Asian countries tended to attribute 
importance more evenly across the underlying forces affecting life expectancy than 
respondents for Africa, as reflected in the more similar sizes of the circles in Figure 23. 
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Figure 23. Cluster relevance and the ranking of highest impact arguments for Asia 
Respondents for Asian countries still attributed the most importance to the 
effectiveness of health care systems (Cl 2, 22% importance), changes in behaviors 
affecting health (Cl 3, 19% importance), and changes in bio-medical technology (Cl 1, 
15% importance). But in contrast to respondents for Africa, more importance was 
attached to differential trends in population sub-groups and less to HIV/AIDS. 
Still, the top five arguments again reflected the importance attached to the 
effectiveness of health care systems, but with “Delivery of reproductive health services, 
including antenatal care services and family planning programs, will be extended” (HD 
2-6) ranked highest. Concern with chronic disease as a cause of death in Asia is 
reflected in the argument “Sedentary lifestyles and changes in diet leading to chronic 
disease risk will increase” (HD 3-1) appearing among the top five. “Improvements in 
the education of women will improve the health of children” (HD 6-4) again had the 
greatest mean net impact score of all the specific arguments, and the greater importance 
assigned to the population sub-group cluster (Cl 6) for Asia resulted in this argument’s 
appearance among the top 5. 
6 Meta-experts’ Assessments of Future Life Expectancy Trends 
On February 10–11, 2011, a meeting of experts was held in Cape Town, South Africa, 
to review, synthesize and critique the survey results and to develop alternative 
scenarios—most likely, optimistic and pessimistic—for future mortality trends in high 
mortality countries. The meeting participants were Rob Dorrington, Tom Moultrie, both 
from the University of Cape Town, Ian Timaeus from the London School of Hygiene 
and Tropical Medicine; Michel Garenne from Institut Pasteur, and Francois Pelletier, 
for the United Nations Populations Division. Initial discussion focused on the unique 
issues in projecting mortality for countries with high mortality: the lack of data for 
determining past trends and current levels of life expectancy, and the inability to predict 
emergent threats and their impacts on future trends. An example of the latter is the 
difficulty posed by the HIV/AIDS epidemic, not just with respect to predicting the 
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epidemic, but also in modeling its future impact. As a group, these experts felt that 
attempting specific projections for individual countries was unwieldy and likely to yield 
inconsistent results, and that the mortality projections should be based on a 
classification of countries that would follow similar trajectories into the future. The 
most obvious starting point for this classification was to separate high mortality 
countries according to their prevalence of HIV/AIDS. 
6.1 Storylines for Low HIV/AIDS Prevalence Countries 
An optimistic scenario for countries that continue to have high mortality implies a 
convergence of forces that would act to dramatically reduce death in infancy and 
childhood, accompanied by improvements in mortality among working aged men and 
women. In most of these countries, this could be maximally achieved by the 
development of a vaccine and improved treatments for malaria that would be both 
effective and made widely available. This, in combination with broad implementation of 
current “best practices” known to reduce deaths from pneumonia, diarrheal diseases, 
and undernutrition (pneumonia vaccination, oral rehydration therapies, food and vitamin 
supplementation) and injuries (especially road accidents) could translate into a five year 
decadal gain in life expectancy. Achievement of this optimal scenario would imply that 
the international community would continue, at a minimum, its current level of funding 
for high mortality countries. In addition, the high mortality countries would have to 
demonstrate the political will to utilize external funding appropriately and to provide 
internal resources to improve health services infrastructure and increase and improve 
education. Improvements in education are crucial since education increases motivation 
to improve health at the individual level, providing benefits over the entire life course. 
With respect to chronic, as opposed to infectious diseases, the most optimistic scenario 
would occur if these high mortality countries benefit from the experience of low 
mortality countries by preventing increases in the behavioral risk factors for chronic 
disease (smoking, obesity, drug and alcohol use).  
The pessimistic scenario was described essentially as the opposite of the 
optimistic scenario. The negative scenario could occur as a consequence of increased 
isolation and reductions in aid from wealthier nations to high mortality countries. 
Within a high mortality country, lowering mortality could be set back by economic 
stagnation or decline. An economic crisis could lead to a reduction in standards of living 
and, in more extreme cases, increased internal or external conflicts. In addition, easy 
solutions would not materialize in the form of long-lasting “magic bullets”; newly 
developed vaccines would prove to be ineffective when scaled up, drug-resistance 
would develop to existing treatments, and non-compliance with treatment regimens 
would increase. Along with this failure to effectively combat mortality from infectious 
diseases, unhealthy behaviors leading to chronic diseases (poor dietary habits, drug and 
alcohol use, and smoking) could increase. The group felt that this scenario would result, 
on average, in a 0.1 year increase in life expectancy over a decade, but that this could 
vary significantly across countries with some countries experiencing declines in life 
expectancy.  
Regionally, all of the high mortality countries outside of Africa have relatively 
low AIDS prevalence, with the exception of Haiti. Even without a high HIV/AIDS 
prevalence, South Asia represents a disproportionate share of the world’s mortality 
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because of its large population size. The meeting participants agreed that the most likely 
scenarios for the most populous countries in this region would be determined by 
progress in reducing infant and child mortality. In general, the meeting participants were 
somewhat less optimistic than the survey experts with respect to the likely future 
scenario for India. These meta-experts felt that it was unlikely that mortality decline 
would continue at as rapid a pace once substantial reductions in child mortality had been 
achieved. The group agreed that a four-year increase for 2020-2030 seemed reasonable, 
somewhat less for 2040-2050, and that a best-case scenario would be an increase of five 
years in both decades. The worst-case scenario would be decadal gains of 1.5 years. For 
Bangladesh, the consensus was that the recent rapid increase in life expectancy was 
likely to continue into the near future, in line with the UN projection. A pessimistic 
scenario for Bangladesh would be only a one year gain per decade, while an optimistic 
scenario wouldn’t be much better than the UN projection, since mortality is now low 
enough that gains will be slower. The consensus opinion regarding the most likely 
course for Pakistan was much less positive. Meeting participants noted that education 
gains in Pakistan have stalled, especially for girls. The probable scenario was seen as a 
slow improvement in life expectancy equal to the UN projection of two years per 
decade. A pessimistic scenario would be a loss of one year per decade, while the 
optimistic scenario would produce a three year per decade gain. 
6.2 Storylines for High HIV/AIDS Prevalence Countries 
The most optimistic scenario for countries severely affected by the HIV/AIDS epidemic 
would imply the development, in the near future, of an effective vaccine that could be 
made available at a reasonable cost. Barring this, a lesser but still optimistic scenario 
could be achieved by maintaining international support for anti-retroviral development 
and treatment. Since the effectiveness of currently available anti-retroviral drugs is less 
than 100 percent, even an optimistic scenario would mean that there would still be many 
AIDS deaths in 30 years, but perhaps not in 50 years. However, the meeting participants 
agreed that current methods for the prevention of mother-to-child transmission of HIV 
could, under optimal circumstances, mean that childhood AIDS could be eliminated. 
This, combined with a broader reduction of infectious disease mortality, especially in 
childhood, could produce decadal life expectancy gains of five years through 2050. 
A pessimistic scenario would imply a continuance of mother-to-child 
transmission and childhood AIDS. Adult AIDS mortality could even increase if funding 
for anti-retroviral treatment diminishes and/or host resistance to these drugs increases. 
An added problem would be that advances against chronic disease mortality could be 
constrained by expanding resources on HIV/AIDS so that little is left for prevention and 
control of other diseases. 
The region most affected by the HIV/AIDS epidemic is Southern Africa. 
According to UNAIDS, the average prevalence rate in 2009 for these five countries was 
21 percent, ranging from 13 percent in Namibia to 26 percent in Swaziland. In terms of 
the most likely scenario for future life expectancy in this region, the general consensus 
was that an effective AIDS vaccine was unlikely to be available in less than 10 years. 
South Africa, the most populous country in the region, was seen as likely to experience 
a three year per decade increase in life expectancy. A pessimistic scenario would result 
in life expectancy stagnating, while an optimistic scenario would result in rapid short-
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term gains allowing South Africa to catch up to the UN non-AIDS projection and then 
follow that trajectory. The meta-experts generally felt that Lesotho was likely to follow 
the pattern set by South Africa, but that Botswana and Swaziland would be different, 
but in ways that were difficult to predict due to the lack of data. 
Eastern Africa is the region with the next highest AIDS prevalence; the average 
across these 15 countries is 5.7 percent, but the range extends from 0.1 percent in 
Comoros to 14.3 percent in Zimbabwe. The situation in Zimbabwe illustrates the 
difficulty with making country-specific projections. Recent data indicate that both 
HIV/AIDS prevalence and mortality have been falling, but explanations for this decline 
remain elusive. Speculation for the cause range from the dire economic situation 
resulting in less travel and less risky behavior overall, to previous high mortality years 
eliminating many HIV infected persons. It was suggested that Kenya would likely 
follow a pattern similar to South Africa because the lower HIV/AIDS prevalence 
(estimated to be 6.3 percent in 2009) would permit effective implementation of anti-
retroviral drug treatment programs. Ethiopia, the largest country in Eastern Africa, also 
presents difficulties due to the paucity of data. The trend projected by the UN for 
Ethiopia is heavily dependent on the future course of child mortality, which appears to 
have declined steadily, with some recent acceleration in the rate of decline. The 
consensus was that the probable trend for Ethiopia was likely to be somewhat better 
than the UN projection. 
The countries of Middle and Northern Africa, on average, have a somewhat 
lower HIV/AIDS prevalence (3.5 percent in 2009), ranging from a low of one percent in 
Sudan to five percent in Cameroon. The meta-experts felt unable to project a specific 
probable course for mortality for this region as a whole or for any of the constituent 
countries due to a lack of data and the history of recent civil conflicts. 
Western Africa has, on average, the lowest HIV/AIDS prevalence in sub-
Saharan Africa (1.8 percent in 2009). Even so, projecting mortality for these countries 
must be done in the context of uncertainty. Nigeria, the largest country in the region, 
epitomizes this problem. The high levels of child mortality in Nigeria imply the 
potential for dramatic decreases, but the meta-experts felt that there was enough 
uncertainly in the Nigerian data to question their use as the basis for future projections. 
The general sense among the meeting participants was that a decadal gain of four years 
in life expectancy was very optimistic, that a gain of only one year somewhat 
pessimistic, and the most likely scenario would be decadal gains of two years. 
7 Combining Expert Assessments and Model Forecasts to Define 
Scenario Assumptions 
For high and low mortality countries the same procedure was applied for defining the 
final assumptions for overall mortality levels for each country. The procedure is 
summarized in (Samir et al. forthcoming) and detailed in the Appendix I by Garbero 
and Sanderson. For the high mortality countries, outcomes of the model-based forecast 
were blended with the assessments of the surveyed experts as described in this paper 
and with results of the meta-expert meeting in Cape Town,South Africa.  
In sum, the statistical model used explicitly assumes convergence in the decadal 
increase of life expectancy. The model also takes into account country-specific 
heterogeneity in the historical trajectories of life expectancy as well as between-
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countries heterogeneity in terms of increases in life expectancy. This reflects the view 
that “national mortality trends should be viewed in a larger international context rather 
than being analysed and projected individually” (Lee 2003). Our model also follows the 
argument of Torri and Vaupel (2012) that life expectancy across different countries 
tends to be positively correlated, so that forecasts for particular countries can be carried 
out by forecasting the best-practice level of life expectancy and then the gap between 
this best-practice level and the particular country’s performance. The model used here 
builds upon this method by varying the speed of convergence, taking into account 
differential rates of linear increase in life expectancy across groups of countries. As 
described in detail in the Appendix I, this is operationalized by choosing Japan as the 
global forerunner with a long-term increase of life expectancy of 2 years per decades. A 
set of regional forerunners is then assumed to converge to this Japanese speed of 
improvement. In a second round, the model then defines the convergence of all 
countries to their respective regional forerunners. This statistical model results in a 
consistent set of projections for all high and low mortality countries except for some 
countries with high AIDS prevalence that required special assumptions as described in 
the technical Appendix I by Garbero and Sanderson. 
The added value of this convergence model lies partly in the fact that it is based 
on empirical data. In addition, it takes into account the heterogeneous country-specific 
historical experiences as well as differences in gains between forerunners and laggards 
over time and across regions. Thus, it accounts for structural as well as stochastic 
components that contribute to life expectancy trends over time and can generate 
unbiased parameters upon which the new forecasts are based. Building further, the 
model-based forecasts were adjusted to incorporate source experts and meta-experts 
arguments and assessments about future gains in life expectancy in individual countries 
up to 2050. This was done by assigning the results of the statistical model the weight of 
1.0, the average of the meta-experts’ responses the weight 1.0 and the specification of 
each individual source expert who made a statement on a given country the weight 0.2. 
The final step consisted of modifying the future trajectories (2050-2095) based on the 
new trend implied by the reweighted forecasts up to 2050, as described in detail in the 
Appendix I. This procedure is applied to female life expectancy, from which male life 
expectancy is derived by assuming the sex-differentials in mortality used in the 2010 
UN assessment. For countries seriously affected by the HIV/AIDS epidemic, the United 
Nations medium scenario, which explicitly models the impact of HIV and AIDS with an 
epidemiological model (Alkema et al. 2007; Brown et al. 2010; Raftery & Bao 2010), is 
used up to 2050. After 2050 life expectancies to the end of the century were projected 
using the model with Namibia as the forerunner country for this group of countries. A 
comparison with the UN assumptions for this period showed very close results. 
The resulting mortality assumptions for each country are listed in tabular 
Appendix II for selected years and in the on-line material for all years. The high and 
low mortality assumptions were derived for all low-mortality countries by the same 
procedure under the simple assumption that the decades gain of the frontrunner is 1.0 
years higher or lower than in the medium assumption. For countries (mostly in sub-
Saharan Africa) with a high prevalence of HIV/AIDS, larger uncertainty intervals were 
assumed for the nearer-term future. In the first decade of the projections, life expectancy 
is assumed for those countries to be five years lower or higher than in the medium. 
After 2020, the “high” mortality scenario for those countries assumes a one year lower 
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decadal gain than in the medium scenario. The “low” mortality scenario assumes an 
additional two years gain per decade on top of the gain from the medium scenario until 
2050, and one year additional gain thereafter. This procedure was only applied to the 
high HIV/AIDS countries in order to reflect the particularly large uncertainties with 
respect to speed for recovering from AIDS, which is also directly linked to the future 
funding of anti-retroviral treatment. 
Education-specific trajectories of life expectancy were then derived by the 
procedure described in Samir et al. (forthcoming), based on the assumption that the 
medium trend in overall life expectancy (across all education groups) as discussed in 
this paper reflects the educational attainment change over time that is implied by the 
Global Education Trend (GET) scenario. Together with the assumption of certain given 
relative differences in education-specific mortality, this procedure produces unique 
iteratively derived sets of education-specific mortality trends for each educational 
attainment category.  
It is worth noting that using different education scenarios together with identical 
sets of education-specific mortality trajectories produces a resulting trajectory of overall 
future life expectancy that is different, because the different education structure of the 
population implies different weights for the sub-populations that each have different 
education-specific mortality rates. In this way the assumed future of education trends is 
also a direct determinant of the future trajectory of the overall level of mortality.  
8 Conclusion 
This paper has highlighted the challenges that attend the estimation of past trends as 
well as the projection of the future course of life expectancy in high mortality countries. 
The challenges revolve around the presence of a large degree of uncertainty that 
encompasses several dimensions.  
First is the uncertainty that surrounds the empirical basis for the estimation of 
past trends and current levels: namely the lack of reliable data on age-specific mortality 
rates, particularly for adults, in this subset of countries. Although the methods employed 
have generated far better estimates than previously available, continual improvement in 
both data and methods is anticipated.  
Second, there is uncertainty that points towards the heterogeneity of trends and 
pathways across this group of countries: in other words, the disparity in terms of past 
trends reinforces the difficulty in making predictions about the future course of life 
expectancy without linking these predictions to the forces determining the progress – or 
lack thereof – in combating the underlying determinants of both child and adult 
mortality peculiar to each of these countries.  
Third, there is uncertainty that revolves around the use of demographic and 
epidemiological models to predict the future of life expectancy in high mortality 
countries, as well as the assumptions regarding the parameters that are at the basis of 
these models. This is particularly true for countries affected by HIV and AIDS where 
assumptions about coverage and efficacy of treatment are key determinants of these 
predictions. 
Fourth, there is uncertainty around expert opinions vis a vis the importance and 
the role of the forces that will shape the future of life expectancy and the direction and 
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magnitude of life expectancy gains. This uncertainty is reflected both in the small 
number of source-experts who provided answers to the high mortality questionnaire, 
and in the meta-experts’ mostly dichotomist view of the future of life expectancy in 
high mortality countries, which could be summarized as a radical versus a more 
conservative view around their vision of the effectiveness of anti-retroviral treatment, 
continued progress towards reducing child and infant mortality, and increasing 
behavioral health risk factors. 
Taking stock of these considerations, the model used to project life expectancy 
in this paper incorporates the various levels of uncertainty through blending an expert-
based approach with a model based approach as described in detail in Appendix I by 
Garbero and Sanderson.  
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Appendix 
List of arguments for assessing future mortality trend in high-mortality countries 
Module 1: Changes in Bio-medical Technology 
HM1-1 Improvements in medical technology will contribute to declining mortality 
HM1-2 Medical care will improve due to therapeutic and diagnostic devices developed 
specifically for low resource areas 
HM1-3 There will be little financial incentive for private pharmaceutical companies to 
invest in research and development (R&D) for new treatments for neglected 
diseases 
HM1-4 Investing in education and in-country research will favor in-country 
development of appropriate biomedical technology 
 
Module 2: Health Care Systems 
HM2-1 Low cost access to essential medicines for broad segments of the population will 
improve 
HM2-2 Increasing user fees for medical services will restrict access to effective and 
timely treatment 
HM2-3 Public-private partnerships will be created for development and implementation 
of successful health strategies 
HM2-4 Basic public health and nutrition interventions (e.g., immunization, 
breastfeeding, vitamin A supplementation and safe drinking water) will be 
expanded to cover more children under the age of 5 
HM2-5 Coverage of inexpensive interventions against diarrhea, pneumonia and malaria 
will be expanded 
HM2-6 Delivery of reproductive health services, including antenatal care services and 
family planning programs, will be extended 
HM2-7 Competing demands will reduce government spending for health care systems 
HM2-8 Investments in education will increase the quality of health personnel 
 
Module 3: Behavioral Changes 
HM3-1 Sedentary lifestyles and changes in diet leading to chronic disease risk will 
increase 
HM3-2 Tobacco consumption will decrease 
HM3-3 Substance abuse (alcohol and drugs) will increase 
HM3-4 Health-enhancing behaviors will spread widely due to mass communication 
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HM3-5 Investments in education will lead people toward more health-inducing 
behaviors 
 
Module 4: Infectious Diseases 
HM4-1 There will be an increase in new infectious diseases 
HM4-2 There will be increasing drug resistance to known infectious diseases 
HM4-3 Increasing standard of living, hygiene and nutrition will improve host-resistance 
to communicable diseases 
HM4-4 Investments in education will increase capability of early detection and control 
to contain the spread and impact of new infectious diseases 
 
Module 5: Environment, Disasters and Wars 
HM5-1 The frequency and intensity of natural disasters (such as flooding and strong 
storms) will increase 
HM5-2 Global warming will lead to an expansion of the malaria zone 
HM5-3 Higher temperature variations will lead to increased diarrheal disease incidence 
HM5-4 Indoor air pollution due to utilization of solid fuels, including biomass (wood, 
dung and crop residues) and coal, will decrease 
HM5-5 Chemical and nuclear contamination will be a major health threat in the future 
HM5-6 There will be more violent civil unrest and wars 
HM5-7 Better education will contribute to decreasing vulnerability to climate change 
 
Module 6: Population Differentials 
HM6-1 Increased social inequality will lead to higher prevalence of poverty, distrust, 
violence and crime 
HM6-2 Investing in education will favour upward social mobility and reduce poverty 
HM6-3 Gender inequalities will decline and will lead to narrowing health gaps between 
men and women 
HM6-4 Improvements in the education of women will improve the health of children 
HM6-5 Health and social services in urban areas will not keep pace with urban 
population growth 
HM6-6 Mortality differentials by level of education will diminish 
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Module 7: HIV/Aids 
HM7-1 Effective vaccines towards HIV and AIDS and TB will be developed within 20 
years 
HM7-2 Anti-retroviral treatment will be effectively implemented to meet the needs of 
populations living in resource-poor settings 
HM7-3 Risky sexual behaviors will impede progress towards reducing the risk of HIV 
and sexually transmitted infections (STDs) 
HM7-4 HIV infection rates will decline most among people with primary and post-
primary education 
HM7-5 More education (not just sexual education but also basic education) will favor 
better prevention and adherence to treatment 
 
 
